Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2020 Annual Meeting | P10 - Poster Session 10

Tuesday 04/28/20
05:30 PM - 06:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Practice, Policy, and Ethics, Aging, Dementia, and Behavioral Neurology, Autoimmune Neurology, Cerebrovascular Disease and Interventional Neurology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuro Trauma, Critical Care, and Sports Neurology, Neuromuscular and Clinical Neurophysiology (EMG)
0.00 credit
Event Timeline
05:30 PM - 06:30 PM Abstract 9-001 - Effect of Nabiximols Cannabinoid Oromucosal Spray on Spasticity and Muscle Strength in Patients with Multiple Sclerosis (MS) Across 3 Randomized Controlled Trials
Francois Bethoux, MD
05:30 PM - 06:30 PM Abstract 9-002 - Patterns of Cognitive and Physical Impairment In A Large, Heterogeneous MS Population: Results From MS PATHS
Tjalf Ziemssen, MD, FÂ鶹´«Ã½Ó³»­
05:30 PM - 06:30 PM Abstract 9-003 - Sex Differences in Cognitive Performance in Multiple Sclerosis
Tomas Uher
05:30 PM - 06:30 PM Abstract 9-005 - Assessing sensorimotor and cognitive function in people with multiple sclerosis is feasible using robotics
Leif Simmatis
05:30 PM - 06:30 PM Abstract 9-006 - A Mindfulness group intervention in newly diagnosed persons with Multiple Sclerosis: a pilot study.
Sarah A. Morrow, MD, MSC, FRCPC, FÂ鶹´«Ã½Ó³»­
05:30 PM - 06:30 PM Abstract 9-007 - Mild cognitive decline in people with relapsing-remitting multiple sclerosis: a major role of structural over functional brain alterations.
Riccardo Manca, Msc
05:30 PM - 06:30 PM Abstract 9-008 - Postprandial Somnolence in People with Multiple Sclerosis
Tatiana L. Christmas, MD
05:30 PM - 06:30 PM Abstract 9-009 - eSupport and eFIT: Internet-based targeted behavioral interventions for persons with multiple sclerosis
Victoria Leavitt, PhD, FÂ鶹´«Ã½Ó³»­
05:30 PM - 06:30 PM Abstract 9-010 - The MSiDMT- a tablet based cognitive assessment tool for MS patients
Rod Middleton
05:30 PM - 06:30 PM Abstract 9-011 - Group Cognitive Rehabilitation Therapy improves Cognitive Function in patients with Multiple Sclerosis
Hugo Marion-Moffet, MD
05:30 PM - 06:30 PM Abstract 9-012 - Multiple Sclerosis Related Fatigue and Autonomic Dysfunction
Jason T. Poon, MD
05:30 PM - 06:30 PM Abstract 9-013 - Screening Predictors of Psychological Reaction to Multiple Sclerosis Diagnosis
05:30 PM - 06:30 PM Abstract 9-014 - Correlations Between Four Common Measures of Cognition in Patients With Secondary Progressive Multiple Sclerosis
Ralph H. Benedict, PhD
05:30 PM - 06:30 PM Abstract 9-015 - OCT Measures as Predictors of Cognitive Function in MS Using Artificial Intelligence
David Chaar, MD
05:30 PM - 06:30 PM Abstract 9-016 - Validation Of Brief International Cognitive Assessment For Multiple Sclerosis In Tunisia
Saloua Mrabet, MD
05:30 PM - 06:30 PM Abstract 9-017 - Micro RNAs (miRNA) Disregulation in Multiple Sclerosis Related Cognitive Impairment; pilot study
Jesus Lovera, MD
05:30 PM - 06:30 PM Abstract 9-018 - Single Digit Modality: What is a Clinically Significant Change in Multiple Sclerosis Patients
Francois H. Jacques, MD
05:30 PM - 06:30 PM Abstract 9-019 - Psychiatric Comorbidities in Multiple Sclerosis among Different Racial and Ethnic Groups: A Nationwide Survey
05:30 PM - 06:30 PM Abstract 9-020 - Multiple Sclerosis Related Pain with Magnetic Resonance Imaging Lesion Localization Correlation and Gender Differences: A Cohort Study
GyeongMo Sohn, MD
05:30 PM - 06:30 PM Abstract 9-021 - Objective Measurement of Cognitive Impairment in Multiple Sclerosis Patients Using Novel Computerized Testing
Roberto Bomprezzi, MD, FÂ鶹´«Ã½Ó³»­
05:30 PM - 06:30 PM Abstract 9-022 - A Prospective Observational Registry Study of Repository Corticotropin Injection for the Treatment of Multiple Sclerosis Relapse
Matthew J. Baker, MD
05:30 PM - 06:30 PM Abstract 15-001 - A Rare Case of Autoimmune Encephalitis in a Patient After Treatment of Metastatic Melanoma with a Combination of Immune Checkpoint Inhibitors Nivolumab and Ipilimumab
Ramya Tadipatri, MD
05:30 PM - 06:30 PM Abstract 15-002 - Sleep disorder, bulbar symptoms and abnormal eye saccades: a case report of anti-IgLON5 antibody syndrome
Shameer Rafee, MBBS, PhD
05:30 PM - 06:30 PM Abstract 15-003 - Steroid Responsive Encephalopathy with Associated Thyroiditis Presenting with Acute Transient Aphasia
Ashley Weng, MD
05:30 PM - 06:30 PM Abstract 15-004 - Acute Inflammatory Myelitis: a pragmatic approach
Micaela Hernandez, MD
05:30 PM - 06:30 PM Abstract 15-005 - Rare Case of Myasthenia Gravis, Parkinsonism, and GAD-65 Antibody Associated Ataxia
Pranusha Pinna, DO
05:30 PM - 06:30 PM Abstract 15-006 - Brazilian autoimmune encephalitis network (BrAIN): preliminary results from a nationwide multicentric study
Fabio F. Toso, MD
05:30 PM - 06:30 PM Abstract 15-007 - Autoimmune encephalitis timing and incidence: the Manitoba experience
Dung H. Nguyen, MD
05:30 PM - 06:30 PM Abstract 15-008 - Anti-NMDA Receptor Encephalitis and Brain Volume Loss
Ann Oh
05:30 PM - 06:30 PM Abstract 15-009 - REM Sleep Without Atonia and Sleep Disturbances in Patients with LGI1 and CASPR2 Autoimmunity
Michelle Devine, MD
05:30 PM - 06:30 PM Abstract 15-010 - Specific Psychiatric Features Identify Anti-NMDAR Encephalitis Before Neurological Deterioration
Cullen M. O'Gorman, MBBS
05:30 PM - 06:30 PM Abstract 15-011 - Frequency and clinical significance of seronegative anti-NMDAR encephalitis
05:30 PM - 06:30 PM Abstract 3-001 - Pharmacokinetics and Biomarker Changes in NILO-PD, A Phase 2A Study of Nilotinib in Patients with Moderate to Advance Parkinson's Disease
Kalpana Merchant
05:30 PM - 06:30 PM Abstract 3-002 - Modeling PD Progression in the PPMI Cohort: Implications for Clinical Trial Design
Christopher Coffey, PhD, FÂ鶹´«Ã½Ó³»­
05:30 PM - 06:30 PM Abstract 3-003 - Validation of Fox Insight Cohort via Virtual Research Visits
Ruth Schneider, MD, FÂ鶹´«Ã½Ó³»­
05:30 PM - 06:30 PM Abstract 3-004 - Minority enrollment in Parkinson’s Disease clinical trials: meta-analysis and systematic review of studies evaluating treatment of neuropsychiatric symptoms.
Daniel Garbin Di Luca, MD
05:30 PM - 06:30 PM Abstract 3-005 - Achieving an optimal profile for immunotherapy of alpha-synucleinopathies: Rational generation of monoclonal antibodies selective for pathogenic forms of alpha-synuclein
Johanne M. Kaplan, PhD
05:30 PM - 06:30 PM Abstract 3-006 - Rationale and Design of a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of AKST4290 in Subjects with Parkinson’s Disease on Stable Dopaminergic Treatment
Jessica Powell
05:30 PM - 06:30 PM Abstract 3-007 - PPMI 2.O New Science/New Cohorts - Transforming PPMI
Kenneth L. Marek, MD
05:30 PM - 06:30 PM Abstract 3-008 - Baseline Characteristics of Participants of the SPARK Trial, a Phase 2 Study of the anti-alpha-synuclein antibody Cinpanemab (BIIB054) in Parkinson’s Disease
Tara Fox
05:30 PM - 06:30 PM Abstract 3-009 - CVT-301 (Inhaled Levodopa) Utilization by Patients With Parkinson’s Disease (PD) in Clinical Studies
William Ondo, MD
05:30 PM - 06:30 PM Abstract 3-011 - Upper Extremity Motor Symptoms’ Severity Estimation with Ecologically Valid Data Arising from Smartphone Touchscreen
Sevasti Bostantjopoulou-Kambouroglou, MD
05:30 PM - 06:30 PM Abstract 3-012 - Multi-Dimensional, Short-Timescale Tablet-Based Quantification of Movement Disorder Symptomatology
John Sanderson, MD
05:30 PM - 06:30 PM Abstract 3-013 - Visualizing Cutaneous Phosphorylated alpha-Synuclein Improves Diagnostic Accuracy in Parkinson’s Disease
Todd D. Levine, MD
05:30 PM - 06:30 PM Abstract 3-014 - Evaluation of Gastric Motility of Parkinson’s Disease Patients Based on a Novel Wearable Device and Time-Frequency Analysis
05:30 PM - 06:30 PM Abstract 3-015 - Dopaminergic Neuronal Imaging in Parkinson’s disease parkin mutation patients and potential pathophysiologic insights of simple heterozygous patients: A clinical DAT-SPECT study
Mario Sousa, MD
05:30 PM - 06:30 PM Abstract 3-016 - Archimedes Spiral Drawing in Idiopathic Parkinson’s Disease Patients Showed More Variability in Jerkiness in Patients with Freezing of Gait
Lakshmi Pillai
05:30 PM - 06:30 PM Abstract 3-017 - Is the UPDRS a Reliable Tool for Detecting the Worse Side in Parkinson’s Disease?
Erin Smith, MD
05:30 PM - 06:30 PM Abstract 12-001 - Relative bioavailability, pharmacokinetic and food effect assessment of two immediate-release formulations of the NaV1.6-selective sodium channel blocker XEN901: Pediatric Granules and Adult Tablets
05:30 PM - 06:30 PM Abstract 12-002 - Assessment of Potential Pharmacokinetic and Pharmacodynamic Interactions between XEN901 (a Novel NaV1.6 Selective Sodium Channel Blocker) and Phenytoin (a non-selective NaV Blocker) in Adult Healthy Subjects
05:30 PM - 06:30 PM Abstract 12-003 - A Phase 1 Study to Assess the Safety, Tolerability and Pharmacokinetics of Two Formulations of a Novel Nav1.6 Sodium Channnel Blocker (XEN901) in Healthy Adult Subjects.
Gregory N. Beatch, PhD
05:30 PM - 06:30 PM Abstract 12-004 - Behavioral Complications from Levetiracetam in the Epilepsy Monitoring Unit
Angela Parsons, DO
05:30 PM - 06:30 PM Abstract 12-005 - A comparative analysis of licensing and reimbursement of anti-epileptic drugs in Canada and Australia
Joshua Tam, MD, PhD
05:30 PM - 06:30 PM Abstract 12-006 - Efficacy of clobazam as an add-on therapy in brain tumor-related epilepsy.
Nupur Brahmbhatt, MD
05:30 PM - 06:30 PM Abstract 12-007 - Initial Data From the Ongoing ENDYMION Open-label Extension Trial of Soticlestat (TAK-935/OV935) in Participants With Developmental and/or Epileptic Encephalopathies (DEE)
Jonathan J. Halford, MD, FÂ鶹´«Ã½Ó³»­
05:30 PM - 06:30 PM Abstract 12-008 - A Phase 1b/2a Study of Soticlestat (TAK-935/OV935) as Adjunctive Therapy in Adults With Developmental and/or Epileptic Encephalopathies (DEE)
Jonathan J. Halford, MD, FÂ鶹´«Ã½Ó³»­
05:30 PM - 06:30 PM Abstract 12-009 - Post Hoc Analysis of Rufinamide Study 022: Adverse Events in Titration vs Maintenance Periods in Patients with Lennox-Gastaut Syndrome
05:30 PM - 06:30 PM Abstract 12-010 - Efficacy, Safety and Need for Dosing Change of Zonisamide During Pregnancy in Women with Epilepsy
Paige Sutton, MD
05:30 PM - 06:30 PM Abstract 12-011 - Pooled Post Hoc Analysis of Treatment-Emergent Adverse Events (TEAEs) by Treatment Period in Patients Aged =12 to <18 and =18 Years from Studies 304, 305, 306, 335, and 332
Sanjeev V. Kothare, MD, FÂ鶹´«Ã½Ó³»­
05:30 PM - 06:30 PM Abstract 6-001 - Development of an algorithm to identify individuals with Neurofibromatosis type 1 within administrative data.
Carolina Barnett Tapia, MD
05:30 PM - 06:30 PM Abstract 6-002 - Reliability of a questionnaire on lifestyle pro-oxidant and antioxidant factors in a multicenter cross-sectional study on ALS
Aliona Cucovici
05:30 PM - 06:30 PM Abstract 6-003 - Burden of disease due to stroke and risk factors in Latin America: an analysis of the Global Burden Disease Study
Kevin Pacheco-Barrios, MD
05:30 PM - 06:30 PM Abstract 6-004 - Genetic and epidemiological study of hereditary ataxia and spastic paraplegia in eastern Quebec
05:30 PM - 06:30 PM Abstract 6-005 - High Â鶹´«Ã½Ó³»­ Better Protects Non-Hispanic than Hispanic Americans against Risk of Stroke: National Health Interview Survey
Golnoush Akhlaghipour, MD
05:30 PM - 06:30 PM Abstract 6-006 - Benchmarking Performance on Administration of Dexamethasone for Bacterial Meningitis
Shefali Dujari, MD
05:30 PM - 06:30 PM Abstract 6-007 - Physical Activity and early onset amyotrophic lateral sclerosis (ALS), Data from the National ALS Registry: 2010 – 2018
Jaime Raymond
05:30 PM - 06:30 PM Abstract 6-008 - Associations Between Outpatient Neurology Dementia Care and Healthcare Utilization
Shaun Ajinkya, MD
05:30 PM - 06:30 PM Abstract 6-009 - Challenges and Limitations of Ascertaining Amyotrophic Lateral Sclerosis (ALS) Cases in the United States
Paul Mehta
05:30 PM - 06:30 PM Abstract 7-001 - Shifting the Balance from Indirect to Direct Patient Care in a Non-Surgical Residency Training Program: a Comprehensive Needs Assessment Study in Neurology Residents
K. H. Vincent Lau, MD
05:30 PM - 06:30 PM Abstract 7-002 - Impact of the Patient Protection and Affordable Care Act on One-year Mortality Risk in Glioblastoma
Nuriel Moghavem, MD
05:30 PM - 06:30 PM Abstract 7-003 - The First Graduate Medical Â鶹´«Ã½Ó³»­-led Quality and Safety Team in the Military at the Largest Health Care System in the United States
Erick M. Roff, DO
05:30 PM - 06:30 PM Abstract 7-004 - Improving Utilization of ICU care: Development of ICH Admission Protocol at a Comprehensive Stroke Center
Parneet K. Grewal, MD
05:30 PM - 06:30 PM Abstract 7-005 - Patient Characteristics Associated with Readmissions in Three Neurology Services at New York University Langone Health (NYULH)
Steven P. Bondi, MD, MPA
05:30 PM - 06:30 PM Abstract 7-006 - Stress Management and Resiliency Training Decreases Stress and Burnout in Neurologists
Leah R. Hanson, PhD
05:30 PM - 06:30 PM Abstract 7-007 - Work-Life Factors, Attitudes, and Wellness Behaviors in Neurology Trainees
Hsien Lee Lau, MD
05:30 PM - 06:30 PM Abstract 7-008 - Acceptance of Telemedicine within an Academic Neurology Department
Meena R. Kannan, MD
05:30 PM - 06:30 PM Abstract 7-010 - Providing an easily accessible online resource for physician wellness advocates
Crystal J. Yeo, MD, PhD
05:30 PM - 06:30 PM Abstract 7-011 - Scope and Adequacy or Disclosure of Conflicts of Interest Between Academic Neurologists and Industry
05:30 PM - 06:30 PM Abstract 7-012 - Improving Stroke Response and Â鶹´«Ã½Ó³»­ at the Southern Arizona Veterans Affairs Health Care System (SAVAHCS)
Veronika Solnicky, MD
05:30 PM - 06:30 PM Abstract 1-001 - Factors that Influence Progression of Respiratory Dysfunction in Myotonic Dystrophy Type 1
Samantha J. LoRusso, MD
05:30 PM - 06:30 PM Abstract 1-002 - Mechanism of Disease in Novel Dominant Skeletal and Cardioskelatal Titinopathies
Jennifer A. Roggenbuck, MS, CGC
05:30 PM - 06:30 PM Abstract 1-004 - Duchenne Muscular Dystrophy (DMD) and Vitamin D deficiency
, Saila Upadhyayula, MD
05:30 PM - 06:30 PM Abstract 1-005 - Abnormal Gyrification in Brain of early onset Myotonic Dystrophy patients
05:30 PM - 06:30 PM Abstract 1-006 - Scapuloperoneal Myopathy and Cardiomyopathy with a Novel MYH7 Mutation: A Case Report
Sara Hooshmand, MD
05:30 PM - 06:30 PM Abstract 1-007 - BAG3 Myopathy in Patient with Prominent Neuropathic Phenotype and no Cardiac or Respiratory Involvement
Lindsay M. Malatesta, MD
05:30 PM - 06:30 PM Abstract 1-008 - Distinctive pathological features of inherited and sporadic late-onset nemaline myopathies
Stefan Nicolau, MD
05:30 PM - 06:30 PM Abstract 1-009 - Second Report of Dominantly Inherited Distal Myopathy Caused by Large Deletion in the Nebulin Gene
05:30 PM - 06:30 PM Abstract 1-010 - Two patients with phosphaturic neuromuscular presentations
Rahul D. Abhyankar, MD
05:30 PM - 06:30 PM Abstract 1-011 - Pathophysiology, Diagnosis and Management of Primary Periodic Paralysis: Identification of Gaps in Knowledge and Competence Among Neurologists
05:30 PM - 06:30 PM Abstract 1-012 - A novel heterozygous mutation in the C-terminal region of HSPB8 leads to limb-girdle rimmed vacuolar myopathy
Stefan Nicolau, MD
05:30 PM - 06:30 PM Abstract 1-013 - An In-Home Study of Facioscapulohumeral Muscular Dystrophy (FSHD) Patients using Contactless Wireless Sensing and Machine Learning
05:30 PM - 06:30 PM Abstract 1-014 - Clinical ,microRNAs,Morphological clues in LGMD D2 (TNPO3-related )Disease Progression.
05:30 PM - 06:30 PM Abstract 10-001 - Brain Functional Connectivity Disruption in a Large Cohort of Patients with Primary Progressive Aphasia
Federica Agosta
05:30 PM - 06:30 PM Abstract 10-002 - Flortaucipir and Neuroinflammation PET in Semantic Dementia
Joseph C. Masdeu, MD, PhD, FÂ鶹´«Ã½Ó³»­
05:30 PM - 06:30 PM Abstract 10-003 - The Role of Alzheimer’s Pathology in Frontotemporal Lobar Degeneration: Resting-State Functional Connectivity Analysis of the Default Mode Network
05:30 PM - 06:30 PM Abstract 10-004 - Diagnostic Utility of Volumetric Brain MRI Quantification for Distinguishing Frontotemporal Dementia from Alzheimer’s Disease
Somayeh Meysami, MD
05:30 PM - 06:30 PM Abstract 10-005 - A Comparison of Automated and Manually-Segmented White Matter Lesions in Primary Progressive Aphasia
05:30 PM - 06:30 PM Abstract 10-006 - The Effect of Social and Leisure Activity Engagement on Cortical Thickness in bvFTD
Nikolas Kinney
05:30 PM - 06:30 PM Abstract 10-007 - [18F]THK-5351 PET Imaging Distinctively Demonstrates Neurodegenerative Changes in Progressive Supranuclear Palsy Concomitant with Cerebellar Ataxia Patient and Amyotrophic Lateral Sclerosis Patient; Case Reports
Yuji Saitoh, MD, FÂ鶹´«Ã½Ó³»­
05:30 PM - 06:30 PM Abstract 10-008 - Association of Serum Homocysteine Level with White Matter Microstructural Integrity in a Non-demented Elderly Population
Mei-jun Shu
05:30 PM - 06:30 PM Abstract 10-009 - Transcranial Cerebral Blood Flow differences in Alzheimer’s Dementia and Vascular Dementia
05:30 PM - 06:30 PM Abstract 10-010 - Irregular Diurnal Rhythmicity and Cerebrovascular Pathology in Older Adults
Rosa Sommer
05:30 PM - 06:30 PM Abstract 4-002 - Safety of Pregnancy After Cerebral Venous Thrombosis: Results From a National Comprehensive Hospital
05:30 PM - 06:30 PM Abstract 4-003 - Cerebral Venous Thrombosis in Argentina: Clinical Characteristics, Epidemiology, Prognosis and Treatment
05:30 PM - 06:30 PM Abstract 4-004 - Prescription of Direct Oral Anticoagulants following Cerebral Venous Sinus Thrombosis
Mariyam Humayun, MD
05:30 PM - 06:30 PM Abstract 4-005 - Difference of cerebral flows in uremia as a cause of encephalopathy. Follow-up by Transcranial Doppler
Leticia Alejandra Olguín-Ramírez, Jr.
05:30 PM - 06:30 PM Abstract 4-006 - Giant Cell Arteritis Presenting with Lingual Artery Infarction
Andres De Leon, MD
05:30 PM - 06:30 PM Abstract 4-007 - Hyponatremia as an independent predictor of mortality and functional outcome in stroke
Maliha Hakim, MD
05:30 PM - 06:30 PM Abstract 4-008 - Frequency and Predictors of Occult Cancer in Ischemic Stroke: A Systematic Review and Meta-Analysis
Bastien Rioux, MD
05:30 PM - 06:30 PM Abstract 4-009 - Underlying Infection is Probably Linked to an Increased Risk of Intrathecal Methotrexate Induced Leukoencephalopathy Mimicking Ischemic Stroke: A Case Series
Maya Hrachova, DO
05:30 PM - 06:30 PM Abstract 4-010 - Clinical Features of Headaches in Ischemic Stroke. A Mexican Series.
Alejandro R. Marfil-Rivera, MD
05:30 PM - 06:30 PM Abstract 4-011 - Amyloid-Beta Related Angiitis of the Central Nervous System: A Case series
Julianne Hall, MD
05:30 PM - 06:30 PM Abstract 4-012 - Multifocal intracranial stenosis associated with Nilotinib
Bhavika Kakadia, DO
05:30 PM - 06:30 PM Abstract 4-013 - Rare Case of Diffuse Cerebral Microhemorrhages from Methotrexate Toxicity in Patient with Acute Lymphoblastic Leukemia
Veronika Solnicky, MD
05:30 PM - 06:30 PM Abstract 4-014 - Reversal of Serotonergic Induced Vasospasm with Cyproheptadine: A Case ReportTo report a case of cyproheptadine used to reverse vasospasm precipitated by Imitrex in a patient with Reversible Cerebral Vasospasm Syndrome (RCVS).
Jennifer Chima, MD
05:30 PM - 06:30 PM Abstract 4-015 - Posterior Sternoclavicular Subluxation - A Rare Mechanism of Stroke
Leighton Mohl, MD
05:30 PM - 06:30 PM Abstract 4-016 - Association Between Spontaneous Cervical Artery Dissection and Changes in Barometric Pressure
Ilana Green, MD
05:30 PM - 06:30 PM Abstract 4-017 - Re-Thinking the ‘Posterior’ in Posterior Reversible Encephalopathy Syndrome: A Single Center Chart Review of 95 Patients
Molly Bates, MD
05:30 PM - 06:30 PM Abstract 4-018 - Atrio-Esophageal Fistula Associated with Stroke: 2 Case Reports Of Rare But Fatal Complication
Ghada A. Mahmoud Mohamed, MD
05:30 PM - 06:30 PM Abstract 4-019 - Magnetic Resonance Vessel Wall Imaging in Central Nervous System Vasculitides: a Case-Series
Matthew Padrick, MD
05:30 PM - 06:30 PM Abstract 4-020 - Serial Vessel Wall Enhancement Change on High-Resolution MRI Vessel Wall Imaging in Primary Angiitis of the Central Nervous System.
05:30 PM - 06:30 PM Abstract 4-021 - Prevalence And Associations of Ischemic Stroke with Pulmonary Arteriovenous Fistulas
Ninad Desai, MBBS
05:30 PM - 06:30 PM Abstract 13-001 - Opsoclonus-myoclonus Syndrome associated with West Nile Encephalitis
Neisha Patel, MD
05:30 PM - 06:30 PM Abstract 13-002 - Acute Inflammatory Demyelinating Polyradiculoneuropathy (AIDP) and Transverse Myelitis: A Tale of West Nile Virus Infection
Jaspreet Johal, MD
05:30 PM - 06:30 PM Abstract 13-003 - What’s hiding in the hair? – An Unusual Case of Ascending Paralysis.
Prashant Natteru, MBBS
05:30 PM - 06:30 PM Abstract 13-004 - Herpes Simplex Virus-1 Encephalitis Mimicking an Acute Stroke
Benjamin T. Alwood, MD
05:30 PM - 06:30 PM Abstract 13-005 - A Case of Hemorrhagic Encephalitis due to Powassan Virus in Pennsylvania
Ryan Hewitt, MD
05:30 PM - 06:30 PM Abstract 13-006 - Powassan Virus: A Diverse Appearing Encephalitis
Christopher B. Traner, MD
05:30 PM - 06:30 PM Abstract 13-007 - Chikungunya Virus Meningoencephalitis: A Case Report
Gabriela A. Lopes, MD
05:30 PM - 06:30 PM Abstract 13-008 - Rapidly progressive dementia and Zika virus infection
Osvaldo J. Nascimento, MD, PhD, FÂ鶹´«Ã½Ó³»­
05:30 PM - 06:30 PM Abstract 13-009 - Neuroinfectious Disease Inquiries within the Emerging Infections Network: Prevalence and Characteristics
Elizabeth Matthews, MD
05:30 PM - 06:30 PM Abstract 13-010 - Varicella-Zoster Virus-associated Longitudinally Extensive Transverse Myelitis in an immunocompetent adult: An unusual and rare complication of Herpes Zoster.
Daniel A. Crespo Artunduaga, MD
05:30 PM - 06:30 PM Abstract 13-011 - A presentation of disseminated VZV causing polyneuritis cranialis without clinical evidence of meningoencephalitis in an immunocompromised patient
Jessica Bloomfield, MD
05:30 PM - 06:30 PM Abstract 13-012 - Neurosyphilis and VZV Encephalitis Coinfection Presenting as a Stroke Mimic
Christopher T. Brewer, MD, PhD
05:30 PM - 06:30 PM Abstract 13-013 - Association of Insomnia and Antiretroviral Treatment in a cohort of HIV-seropositive Women
Ernesto Borrero-Quintana, MD, PhD
05:30 PM - 06:30 PM Abstract 13-014 - Progressive Multifocal Leukoencephalopathy Associated with Idiopathic CD4+ Lymphocytopenia in a Patient with Heterozygous STAT4 Mutation
05:30 PM - 06:30 PM Abstract 13-015 - HIV-Associated Neurocognitive Disorders at Moi Teaching and Referral Hospital, Eldoret, Kenya.
Amina A. Mohamed, MD
05:30 PM - 06:30 PM Abstract 13-016 - Long term survival and 9-year follow-up of 14 HIV-infected adults with Progressive Multifocal Leucoencephalopathy
Mahmoud A. AbdelRazek, MD
05:30 PM - 06:30 PM Abstract 13-017 - Effect of teriflunomide on JCPyV infection in primary astrocytes and choroid plexus epithelial cells
Walter J. Atwood, PhD
05:30 PM - 06:30 PM Abstract 13-018 - Reversible Small Vessel Vasculitis and Encephalitis in the Context of Anti-Retroviral Resistance: A Manifestation of Central Nervous System HIV Escape
Ryan T. Muir, MD
05:30 PM - 06:30 PM Abstract 5-001 - Mild Traumatic Brain Injury and Neuropsychiatric Sequelae in the Pediatric Population
Maryamnaz Zaribaf, MD
05:30 PM - 06:30 PM Abstract 5-002 - A Supervised Exercise Challenge Detects Dizziness More Frequently Than Symptom Reporting and Vestibular/Ocular-Motor Screening in Adolescent Concussion Patients
Michael Popovich, MD
05:30 PM - 06:30 PM Abstract 5-003 - The prevalence of concentration deficits in pediatric concussion patients
Avy Ronay, MD
05:30 PM - 06:30 PM Abstract 5-004 - Baseline Concussion Symptom Score Differences Comparing Collision, Contact, and Noncontact Sports and Comparison of Between Sexes
Andrew R. Sas, MD, PhD
05:30 PM - 06:30 PM Abstract 5-005 - Orthostatic Vitals as a Diagnostic Tool for Sport-Related Concussion
Andrew R. Sas, MD, PhD
05:30 PM - 06:30 PM Abstract 5-006 - Reflex syncope as cause and effect of concussion related dysautonomia in a collegiate athlete
Paige Buddenhagen
05:30 PM - 06:30 PM Abstract 5-007 - The 5 Modifying Factors of Concussion
Said Shukri, MD
05:30 PM - 06:30 PM Abstract 5-008 - Effects of Pre-Accident History of Migraine on Acute Concussion Symptoms and Recovery: The Toronto Concussion Study
05:30 PM - 06:30 PM Abstract 5-009 - Convergence Insufficiency in the Division I Athlete
Nicholas S. Streicher, MD
05:30 PM - 06:30 PM Abstract 5-010 - Association of MULES performance and S3SE Symptom Domains in College Students
Hunaid Hasan, MD
05:30 PM - 06:30 PM Abstract 5-011 - Precision-Medicine in Post-Concussion Syndrome by Relating Subject Specific Structural-Functional Connectomes and Neuropsychological Measures
05:30 PM - 06:30 PM Abstract 5-012 - Utility of Automated Pipeline for Assessment of Regional Brain Volumes in Chronic Traumatic Brain Injury (TBI)
Faculty Disclosures
Chelsea S. Kidwell, MD No disclosure on file
Anthony E. Lang, MD, FÂ鶹´«Ã½Ó³»­ Dr. Lang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie, Amylyx, Aprinoia, Biogen, BioAdvance, Biohaven, BioVie, BlueRock, BMS, Denali, Janssen, Lilly, Pharma 2B, Sun Pharma, and UCB. Dr. Lang has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for medicolegal cases related to paraquat. The institution of Dr. Lang has received research support from AbbVie. Dr. Lang has received intellectual property interests from a discovery or technology relating to health care. Dr. Lang has received publishing royalties from a publication relating to health care.
Josep O. Dalmau, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³»­. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care.
Roy L. Freeman, MD Dr. Freeman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cutaneous Diagnostic Life Sciences. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theravance. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Inhibikase. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Freeman has received research support from NIH. The institution of Dr. Freeman has received research support from Theravance. The institution of Dr. Freeman has received research support from Biohaven. The institution of Dr. Freeman has received research support from Lundbeck. Dr. Freeman has received research support from Regeneron.
Neil A. Busis, MD, FÂ鶹´«Ã½Ó³»­ Dr. Busis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Â鶹´«Ã½Ó³»­. Dr. Busis has received personal compensation in the range of $0-$499 for serving as a Consultant for American Medical Association. Dr. Busis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Today. Dr. Busis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Clinical Practice.
Michael R. Sperling, MD, FÂ鶹´«Ã½Ó³»­ Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. The institution of Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for International Medical Press. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Projects for Knowledge. The institution of Dr. Sperling has received research support from SK Life Science. The institution of Dr. Sperling has received research support from UCB Pharma . The institution of Dr. Sperling has received research support from Takeda. The institution of Dr. Sperling has received research support from Neurelis. The institution of Dr. Sperling has received research support from Engage Therapeutics . The institution of Dr. Sperling has received research support from Medtronic. The institution of Dr. Sperling has received research support from Cavion. The institution of Dr. Sperling has received research support from Xenon Pharma. The institution of Dr. Sperling has received research support from Cerevel. The institution of Dr. Sperling has received research support from National Institutes of Health . The institution of Dr. Sperling has received research support from DARPA. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Vice President with Epilepsy Consortium .
Michael Silber, MB, ChB, FÂ鶹´«Ã½Ó³»­ Dr. Silber has received publishing royalties from a publication relating to health care. Dr. Silber has received personal compensation in the range of $500-$4,999 for serving as a Topic writer with UpToDate.
Jacqueline French, MD, FÂ鶹´«Ã½Ó³»­ Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation. The institution of Dr. French has received research support from Epilepsy Study Consortium/ Epilepsy Foundation (Funded by UCB). The institution of Dr. French has received research support from GW/One8 Foundation/FACES. The institution of Dr. French has received research support from NINDS. The institution of Dr. French has received research support from Xenon. The institution of Dr. French has received research support from Cerevel. The institution of Dr. French has received research support from FACES. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Epilepsy Study Consortium. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Praxis. Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as a Chief Medical/Innovation Officer with Epilepsy Foundation. Dr. French has a non-compensated relationship as a Consultant with Acadia Pharmaceuticals Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a consultant with Access Industries that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a consultant with Acuta Capital Partners LLC that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with AFASCI Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Agrithera, Inc. that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Alkermes that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a consultant with Alterity Therapeutics Limited that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Angelini Pharma S.p.A. that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Autifony Therapeutics Limited that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Axonis Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bain Capital that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Beacon Biosciences that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biogen that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biohaven Pharma that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Bloom Science, Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bright Minds Biosciences, Inc. that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Capsidia Biotherapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Cerebral Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerecin, Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Cerevel that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consulting, SAB with Cognizance Biomarkers that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consulting with Ceribell that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cowen that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Crossject that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with EcoR1 Capital that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with EG 427 that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a consultant, Advisory Board with Eisai that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Encoded Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant/Advisory Board with Engrail that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Epitel, Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with EpiMinder that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Grin Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Harmony that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with Ionis Pharmaceutical that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with iQure Pharma, Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with IQVIA that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Janssen Pharma that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Jazz Pharmaceutical that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Leal Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, with Livanova that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with London Research & Pharmaceuticals that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Longboard Pharmaceutical that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Maplight Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Marinus that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Medscape/Web MD that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a consultant with Modulight Bio that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Montara Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Mosaica Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a consultant with Neumarker that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Neumirna Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neurelis that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a consulting, Advisory Board with Neurocrine that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a consultant with Neuropace that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with NeuroPro Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consulting with Neuroventis that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consulting with Neurona Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consulting, Advisory Board with Neuvarti that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Noema that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consulting with Ono Pharmaceutical that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consulting, Advisory Board with Otsuka that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a consulting, Advisory Board with Ovid Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consulting with Praxis that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with PureTech LYT Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with QurAlis Corp that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Rapport Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Receptor Holdings, Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Rivervest Venture Partners that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Sage Therapeutics, Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with SK Life Science that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Stoke that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Stream Neuroscience that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Supernus that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Takeda that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Taysha Gene Therapies that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with UCB, Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with uniQure that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Ventus Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Vida Ventures Management that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Xenon Pharmaceuticals that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Karl D. Kieburtz, MD Dr. Kieburtz has received personal compensation for serving as an employee of Clintrex Research Corporation. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Kieburtz has stock in Clintrex Research Corp. Dr. Kieburtz has stock in Hoover Brown. An immediate family member of Dr. Kieburtz has stock in Hoover Brown. Dr. Kieburtz has stock in Safe Therapeutics. The institution of Dr. Kieburtz has received research support from NIH. The institution of Dr. Kieburtz has received research support from Michae J Fox Foundation.
Bradley F. Boeve, MD, FÂ鶹´«Ã½Ó³»­ Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Caroline M. Tanner, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Evidera. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals/Cavion. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial . Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Genentech. The institution of Dr. Tanner has received research support from Gateway LLC. The institution of Dr. Tanner has received research support from Roche\Genentech. The institution of Dr. Tanner has received research support from Michael J Fox Foundation . The institution of Dr. Tanner has received research support from National Institute of Health . The institution of Dr. Tanner has received research support from Department of Defense. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Faculty, CME presentation with Medscape /WebND.
Bradford B. Worrall, MD, MSc, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Worrall has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³»­. The institution of Dr. Worrall has received research support from NIH. The institution of Dr. Worrall has received research support from AHA/ASA.
Hubert H. Fernandez, MD, FÂ鶹´«Ã½Ó³»­ Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intrance. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Fernandez has received publishing royalties from a publication relating to health care. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as a Steering Committee/Advisory Committee Member with Parkinson Study Group.
Gustavo C. Roman, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Roman has received research support from Brain Chamistry Labs.
Kimford J. Meador, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Meador has received research support from NIH. The institution of Dr. Meador has received research support from The Epilepsy Consortium.
Massimo Filippi, MD, FÂ鶹´«Ã½Ó³»­ Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Amit Bar-Or, MD, FRCPC Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for cabaletta. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech.
David K. Simon, MD, PhD Dr. Simon has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Bial Biotech. An immediate family member of Dr. Simon has stock in Biogen. The institution of Dr. Simon has received research support from Weston Brain Institute. The institution of Dr. Simon has received research support from NIH. The institution of Dr. Simon has received research support from Neuraly. Dr. Simon has received personal compensation in the range of $5,000-$9,999 for serving as a Steering Committee Member: SPARK clinical study with Biogen. Dr. Simon has received personal compensation in the range of $500-$4,999 for serving as a Steering Committee Member: NILO-PD clinical study with Michael J Fox Foundation.
Argye E. Hillis, MD, MA Dr. Hillis has received personal compensation for serving as an employee of Johns Hopkins University. Dr. Hillis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Hillis has received research support from NIH. Dr. Hillis has received publishing royalties from a publication relating to health care. Dr. Hillis has received personal compensation in the range of $500-$4,999 for serving as a NIDCD Council Member with NIH.
Richard A. Rudick, MD, FÂ鶹´«Ã½Ó³»­ Dr. Rudick has received personal compensation for serving as an employee of Biogen. Dr. Rudick has received stock or an ownership interest from Biogen. Dr. Rudick has received publishing royalties from a publication relating to health care.
Corrado Angelini, MD, FÂ鶹´«Ã½Ó³»­ Dr. Angelini has nothing to disclose.
Jesse M. Cedarbaum, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Joseph C. Masdeu, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Masdeu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lilly . The institution of Dr. Masdeu has received research support from NIH. The institution of Dr. Masdeu has received research support from Houston Methodist Foundation. The institution of Dr. Masdeu has received research support from Alector. The institution of Dr. Masdeu has received research support from Aviado-Bio. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received personal compensation in the range of $100,000-$499,999 for serving as a Director, Nantz Nal Alzheimer Center with HOUSTON METHODIST NEUROLOGICAL INSTITUTE.
Tudor G. Jovin, MD Dr. Jovin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Jovin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Contego Medical. Dr. Jovin has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Several law firms. Dr. Jovin has stock in Corindus. Dr. Jovin has stock in Methinks. Dr. Jovin has stock in Viz.ai. Dr. Jovin has stock in Route92. Dr. Jovin has stock in FreeOx Biotech. Dr. Jovin has stock in Galaxy. Dr. Jovin has stock in Kandu. The institution of Dr. Jovin has received research support from Stryker. The institution of Dr. Jovin has received research support from Medtronic.
Carmela Tartaglia, MD Dr. Tartaglia has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Tartaglia has received research support from NIH. The institution of Dr. Tartaglia has received research support from University of Toronto.
Ronald Postuma, MD Dr. Postuma has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche, Biogen, Takeda, Theranexus, GE, Jazz, Curasen, Paladin, Inception Sciences, Phytopharmics, Vaxxinity, Merck. Dr. Postuma has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen/Partners. The institution of Dr. Postuma has received research support from CIHR, Weston Foundation, Webster Foundation, Roche, MJFF, Parkinson Canada, FRSQ, NIH.
Douglas Galasko, MD Dr. Galasko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly, Inc. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Diagnostics. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognition THeraprutics. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Artery Therapeutics.
Julie A. Schneider, MD, MS Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alnylam. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for apellis. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for National Hockey League. The institution of Dr. Schneider has received research support from NIH. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a scientific advisor with Fondation Alzheimer, France.
Barbara Voetsch, MD, PhD The institution of Dr. Voetsch has received research support from NIH StrokeNet . Dr. Voetsch has received publishing royalties from a publication relating to health care. Dr. Voetsch has received personal compensation in the range of $500-$4,999 for serving as a International Stroke Conference attendee (travel-related expenses) with AHA/ASA. Dr. Voetsch has received personal compensation in the range of $500-$4,999 for serving as a member of the Quality Metrics Subcommittee (travel-related expenses) with Â鶹´«Ã½Ó³»­. Dr. Voetsch has a non-compensated relationship as a member of the Massachusetts Systems of Care Workgroup with AHA/ASA that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
William Ondo, MD Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TEVA. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ACADIA. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ACADIA. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Ondo has received research support from Fascicle. The institution of Dr. Ondo has received research support from Cerevance. The institution of Dr. Ondo has received research support from AskBio. Dr. Ondo has received publishing royalties from a publication relating to health care.
Katalin Scherer, MD No disclosure on file
Kenneth L. Marek, MD Dr. Marek has received personal compensation for serving as an employee of IND. Dr. Marek has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for invicro. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for takeda. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Denali. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Koneksa. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Xingimaging. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuron23. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Marek has received research support from Michael J Fox Foundation.
Bruce A. Cree, MD, PhD, MAS, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. The institution of Dr. Cree has received research support from Kyverna. Dr. Cree has received publishing royalties from a publication relating to health care.
Erik K. St. Louis, MD The institution of Dr. St. Louis has received research support from NIH. Dr. St. Louis has received publishing royalties from a publication relating to health care. Dr. St. Louis has received publishing royalties from a publication relating to health care.
Andrew G. Engel, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Engel has received research support from NIH.
Robert J. Fox, MD, FÂ鶹´«Ã½Ó³»­ Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria Biologica. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InnoCare Pharma. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Fox has received research support from National Institutes of Health. The institution of Dr. Fox has received research support from National MS Society. Dr. Fox has received publishing royalties from a publication relating to health care.
Francesc R. Graus, MD Dr. Graus has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink. Dr. Graus has received intellectual property interests from a discovery or technology relating to health care.
David J. Brooks, MD, DSc, FRCP No disclosure on file
Carolina Ionete, MD Dr. Ionete has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Ionete has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Zenas. Dr. Ionete has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Ionete has received research support from Genetech. The institution of Dr. Ionete has received research support from NIH.
Jorge D. Correale, MD Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Correale has received research support from Merck. The institution of Dr. Correale has received research support from Biogen. The institution of Dr. Correale has received research support from Novartis .
Andrew McKeon, MD The institution of Dr. McKeon has received research support from National Institutes of Health. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received publishing royalties from a publication relating to health care.
Carlos Singer, MD Dr. Singer has nothing to disclose.
Patrick Vermersch Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS-Celgene. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ad Scientiam. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for La revue des microbiotes. The institution of Patrick Vermersch has received research support from Roche. The institution of Patrick Vermersch has received research support from Sanofi.
Nicolas Dupre, MD, FÂ鶹´«Ã½Ó³»­ Dr. Dupre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea Therapeutics Canada. The institution of Dr. Dupre has received research support from ARSACS Foundation. The institution of Dr. Dupre has received research support from CHUdeQuebec Foundation.
Vincenzo Silani, MD, FÂ鶹´«Ã½Ó³»­ Dr. Silani has nothing to disclose.
Paola Caroppo Paola Caroppo has nothing to disclose.
No disclosure on file
Paola Valsasina Paola Valsasina has nothing to disclose.
Ralph H. Benedict, PhD Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic Therapeutics. Dr. Benedict has received intellectual property interests from a discovery or technology relating to health care.
Heinz Reichmann, MD, FÂ鶹´«Ã½Ó³»­ Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zambon. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyowa. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zambon. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wissenschaftsverlag.
Annalena Venneri, PhD No disclosure on file
Michael Schwarzschild, MD, PhD The institution of Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial Biotech (indirectly, as a service of the Parkinson Study Group service). The institution of Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen (indirectly, as a service of the Parkinson Study Group service). The institution of Dr. Schwarzschild has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB (indirectly, as a service of the Parkinson Study Group service). Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. The institution of Dr. Schwarzschild has received research support from NIH. The institution of Dr. Schwarzschild has received research support from Parkinson's Foundation. The institution of Dr. Schwarzschild has received research support from Michael J Fox Foundation. The institution of Dr. Schwarzschild has received research support from Farmer Family Foundation. Dr. Schwarzschild has a non-compensated relationship as a Chair, Executive Committee with the Parkinson Study Group that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Federica Agosta Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
Giuseppe Magnani Giuseppe Magnani has nothing to disclose.
Ludwig Kappos, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kappos has nothing to disclose.
Mario F. Mendez, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medical Â鶹´«Ã½Ó³»­ Speakers' Bureau. Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Mendez has received research support from NIH. Dr. Mendez has received publishing royalties from a publication relating to health care.
Andrew D. Siderowf, MD Dr. Siderowf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer-Ingelheim. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for askbio. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for capsida. Dr. Siderowf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Parkinson Study Group. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theravance. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prilenia. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurogastrix. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prevail. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alerity. Dr. Siderowf has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Clintrex. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. Dr. Siderowf has a non-compensated relationship as a Scientific Advisory Board with NeuroPacs that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Ramon R. Diaz-Arrastia, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Diaz-Arrastia has stock in BrainBox, LLC. Dr. Diaz-Arrastia has stock in Nia Therpeutics. The institution of Dr. Diaz-Arrastia has received research support from National Institutes of Health. The institution of Dr. Diaz-Arrastia has received research support from Department of Defense.
Mark R. Keezer, MD, PhD The institution of Dr. Keezer has received research support from TD Bank. The institution of Dr. Keezer has received research support from Savoy Foundation. The institution of Dr. Keezer has received research support from Canadian Institutes of Health Research. The institution of Dr. Keezer has received research support from Fonds de Recherche Québec Santé. The institution of Dr. Keezer has received research support from Canadian Institutes of Health Research. The institution of Dr. Keezer has received research support from Precision Child Health Partnership Catalyst Program.
Richard S. Nicholas, FRCP Dr. Nicholas has nothing to disclose.
Eva Havrdova, MD Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Christopher H. Gibbons, MD, FÂ鶹´«Ã½Ó³»­ Dr. Gibbons has received personal compensation for serving as an employee of CND Life Sciences. Dr. Gibbons has or had stock in CND Life Sciences.Dr. Gibbons has received publishing royalties from a publication relating to health care.
Xavier Montalban, MD, PhD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIAL PD. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVoice. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung Biosys. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas BioPharma. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen Pharmaceuticals. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received research support from BMS/ Celgene.
Fabrizio Stocchi Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bial, Biogen, Sunovion, Lundbeck, UCB, Zambon, Chiesi, Lusofarmaco, Abbvie, Neuroderm, Kyowa, Synegile, Roche, Britannia, Sunovion, Blue Rock. Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL, Zambon, Biogen, Roche, Synegile, Sunovion. Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bial, Zambon, UCB, Kyowa, Sunovion.
Daniel Ontaneda, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Ontaneda has received research support from NIH. The institution of Dr. Ontaneda has received research support from PCORI. The institution of Dr. Ontaneda has received research support from NMSS. The institution of Dr. Ontaneda has received research support from Genetech.
Gavin Giovannoni, MD Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck KGaA. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche-Genentech. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astoria Biologica. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape.
Manuela Vaneckova Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Manuela Vaneckova has received research support from Czech Ministry of Health project—grants NU 22-04-00193 . Manuela Vaneckova has received research support from Czech Ministry of Health project - RVO VFN 64165 . Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving as a principal investigator with Czech Ministry of Health project—grants NU 22-04-00193 .
Niall Tubridy, MD Dr. Tubridy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis .
Sanjeev V. Kothare, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kothare has nothing to disclose.
John M. Bertoni, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Bertoni has nothing to disclose.
Eduardo S. Tolosa, MD Dr. Tolosa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prevail. Dr. Tolosa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MSD . Dr. Tolosa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Tolosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Tolosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie . Dr. Tolosa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Boehringer Ingelheim. Dr. Tolosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ever Neuropharm. Dr. Tolosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Esteve. The institution of Dr. Tolosa has received research support from Instituto de Salud CArlos III. Dr. Tolosa has received research support from MJFF. Dr. Tolosa has received publishing royalties from a publication relating to health care.
Olivier Rascol, MD, PhD Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie, Acorda, Aguettant, Alkahest, AlzProtect, Apopharma, Astrazeneca, Axovant, Bial, Biogen, Britannia, Buckwang, Centogene, Cerevel, Clevexel, Contera, GE Healthcare, Handltherapeutic, Ionis, Irlab, Jazz, Kyowa, LGD Nuvamid, Lundbeck, Merck, Merz, MundiPharma, Neuralight, Neuratris, Neuroderm, Novartis, ONO Pharma, Orion Pharma, Osmotica, Oxford Biomedica, Parexel, PD Neurotechnology, Pfizer, Polycaps, Prexton, Roche Therapeutics, Sanofi, Scienture, Servier,Sombiotech, Sunovion, Supernus, Synagile, Thelonius Mind, Takeda, Théranexus, Teva, Tools4patient, UCB, Vision 2 voice, XenoPort, XO, Zambon . Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie, Acorda, Aguettant, Alkahest, AlzProtect, Apopharma, Astrazeneca, Axovant, Bial, Biogen, Britannia, Buckwang, Centogene, Cerevel, Clevexel, Contera, GE Healthcare, Handltherapeutic, Ionis, Irlab, Jazz, Kyowa, LGD Nuvamid, Lundbeck, Merck, Merz, MundiPharma, Neuralight, Neuratris, Neuroderm, Novartis, ONO Pharma, Orion Pharma, Osmotica, Oxford Biomedica, Parexel, PD Neurotechnology, Pfizer, Polycaps, Prexton, Roche Therapeutics, Sanofi, Scienture, Servier,Sombiotech, Sunovion, Supernus, Synagile, Thelonius Mind, Takeda, Théranexus, Teva, Tools4patient, UCB, Vision 2 voice, XenoPort, XO, Zambon . Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIAL. Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MEDIZIN ACADEMY. The institution of Dr. Rascol has received research support from Agence Nationale de la Recherche (ANR), CHU de Toulouse, France-Parkinson, INSERM-DHOS Recherche Clinique Translationnelle, MJFox Foundation, Programme Hospitalier de Recherche Clinique, European Commission (FP7, H2020).
Werner Poewe, MD Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Affiris . Werner Poewe, MD has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alterity, AbbVie, BIAL, Biogen, Britannia, Lilly, Lundbeck, Neuroderm, Neurocrine, Denali Pharmaceuticals, ,Roche, Takeda, UCB and Zambon . Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie, Britannia, BIAL, STADA, Lundbeck, Zambon. The institution of Werner Poewe, MD has received research support from MJFF; EU Horizon programme. Werner Poewe, MD has a non-compensated relationship as a Committee member with Movement Disorder Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Tanya Simuni, MD, FÂ鶹´«Ã½Ó³»­ Dr. Simuni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for cadia, AcureX, Adamas, AskBio, Amneal, Blue Rock Therapeutics, Caraway Therapeutics, Critical Path for Parkinson's Consortium (CPP), Denali, Michael J Fox Foundation, Neuroderm, Sanofi, Sinopia, Roche, Takeda and Vanqua Bio. Dr. Simuni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for of Koneksa, Neuroderm, Sanofi, UCB, AcureX, Adamas, AskBio, Biohaven, Denali, GAIN, Neuron23 and Roche. Dr. Simuni has received research support from Amneal, Biogen, Neuroderm, Prevail, Roche, and UCB and an investigator for NINDS, MJFF, Parkinson's Foundation.
Jaya Trivedi, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Trivedi has received research support from Avidity.
David G. Munoz, MD No disclosure on file
Jeffrey L. Elliott, MD No disclosure on file
Osvaldo J. Nascimento, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Nascimento has nothing to disclose.
Basil Sharrack, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Sharrack has nothing to disclose.
Ellen M. Mowry, MD, FÂ鶹´«Ã½Ó³»­ Dr. Mowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octave. Dr. Mowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SetPoint. The institution of Dr. Mowry has received research support from Genentech/Roche. The institution of Dr. Mowry has received research support from Biogen. Dr. Mowry has received publishing royalties from a publication relating to health care.
Ebrima Gibbs, Bsc, BMLSc, MSc Dr. Gibbs has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Promis Neurosciences.
Diego Cadavid, MD, FÂ鶹´«Ã½Ó³»­ Dr. Cadavid has received personal compensation for serving as an employee of Verge Genomics. Dr. Cadavid has received personal compensation for serving as an employee of Vertex Pharmaceuticals. Dr. Cadavid has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. Dr. Cadavid has or had stock in Verge Genomics.Dr. Cadavid has or had stock in Vertex Pharmaceuticals.
Carlos Perdomo No disclosure on file
Margherita Milone, MD, FÂ鶹´«Ã½Ó³»­ Dr. Milone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian Therapeutics. Dr. Milone has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics, Â鶹´«Ã½Ó³»­. The institution of Dr. Milone has received research support from Mayo Clinic, CCaTS-CBD. The institution of Dr. Milone has received research support from Mayo Clinic, SGP Award. The institution of Dr. Milone has received research support from MDA for Care Center grant. The institution of Dr. Milone has received research support from Regenerative medicine Minnesota.
Matthew T. Lorincz, MD, PhD Dr. Lorincz has received personal compensation for serving as an employee of Alexion. Dr. Lorincz has received personal compensation for serving as an employee of Orphalon . Dr. Lorincz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Lorincz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orphalon . Dr. Lorincz has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink Neurology. The institution of Dr. Lorincz has received research support from Alexion.
David A. Bennett, MD Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annovis. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for New Amsterdam. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie.
Philip De Jager, MD, PhD Dr. De Jager has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Puretech. Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for roche. Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. The institution of Dr. De Jager has received research support from roche. The institution of Dr. De Jager has received research support from puretech.
Jessica D. Lee, MD, FÂ鶹´«Ã½Ó³»­ Dr. Lee has received personal compensation for serving as an employee of Â鶹´«Ã½Ó³»­. The institution of Dr. Lee has received research support from Janssen.
John W. Rose, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Rose has received research support from National Multiple Sclerosis Society. The institution of Dr. Rose has received research support from Guthy Jackson Charitable Foundation. The institution of Dr. Rose has received research support from NIH . The institution of Dr. Rose has received research support from VA. The institution of Dr. Rose has received research support from Biogen. The institution of Dr. Rose has received research support from Friends of MS. Dr. Rose has received intellectual property interests from a discovery or technology relating to health care.
Paul E. Schulz, MD Dr. Schulz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisa .
Ken Uchino, MD Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aboott Laboratories, Inc.. Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ACP JOURNAL CLUB. The institution of Dr. Uchino has received research support from NIH.
Tjalf Ziemssen, MD, FÂ鶹´«Ã½Ó³»­ Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS . Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Dresden Internation University. The institution of Dr. Ziemssen has received research support from Novartis. The institution of Dr. Ziemssen has received research support from Merck. The institution of Dr. Ziemssen has received research support from Sanofi. The institution of Dr. Ziemssen has received research support from BMS. The institution of Dr. Ziemssen has received research support from Roche.
Panayiotis N. Varelas, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Varelas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Varelas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astra Zeneca -Alexion - Portola. Dr. Varelas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Varelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca- Alexion-Portola. Dr. Varelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus. Dr. Varelas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Varelas has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Giammarco, Mullins & Horton P.C. Dr. Varelas has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Un of Michigan. The institution of Dr. Varelas has received research support from Marinus. The institution of Dr. Varelas has received research support from Bayer. Dr. Varelas has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Varelas has received personal compensation in the range of $5,000-$9,999 for serving as a Rep to the RUC meeting with Â鶹´«Ã½Ó³»­. Dr. Varelas has received personal compensation in the range of $500-$4,999 for serving as a Speaker at the Annual Meeting with Â鶹´«Ã½Ó³»­. Dr. Varelas has a non-compensated relationship as a President - Past President with Neurocritical Care Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Deidre J. Devier, PhD No disclosure on file
Todd D. Levine, MD Dr. Levine has received personal compensation for serving as an employee of CND life sciences . Dr. Levine has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Nufactor. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for PNA. Dr. Levine has or had stock in CND Life Sciences.Dr. Levine has or had stock in Corinthian reference lab.
Rima Dafer, MD Dr. Dafer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Dafer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Dafer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Anderson, Rasor, and partners.
Marie-Helene Saint-Hilaire, MD, FRCPC, FÂ鶹´«Ã½Ó³»­ Dr. Saint-Hilaire has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Altec. Dr. Saint-Hilaire has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for advarra. Dr. Saint-Hilaire has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parkinson study group.
Jesus Lovera, MD Dr. Lovera has nothing to disclose.
Jonathan P. Gladstone, MD Dr. Gladstone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lily. Dr. Gladstone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Gladstone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Gladstone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lily. Dr. Gladstone has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Gladstone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Gladstone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Gladstone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aralez. Dr. Gladstone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Gladstone has received publishing royalties from a publication relating to health care.
Nir Giladi, MD, FÂ鶹´«Ã½Ó³»­ Dr. Giladi has received personal compensation in the range of $0-$499 for serving as a Consultant for Sionara. Dr. Giladi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroDerm. Dr. Giladi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pharma2B. Dr. Giladi has stock in Vibrant. Dr. Giladi has stock in Lysosomal Therapeutics . The institution of Dr. Giladi has received research support from The Michael J Fox Foundation. The institution of Dr. Giladi has received research support from The National Parkinson Foundation. The institution of Dr. Giladi has received research support from The European Union . The institution of Dr. Giladi has received research support from The Israel Science Foundation. The institution of Dr. Giladi has received research support from Biogen . The institution of Dr. Giladi has received research support from Ionis. The institution of Dr. Giladi has received research support from Sieratzki Family Foundation . The institution of Dr. Giladi has received research support from The Aufzien Academic Center in Tel-Aviv University.
Nagagopal Venna, MBBS, FÂ鶹´«Ã½Ó³»­ Dr. Venna has nothing to disclose.
David F. Tang-Wai, MD, FRCPC Dr. Tang-Wai has nothing to disclose.
Minhua Yang No disclosure on file
Tatiana Foroud, PhD The institution of Dr. Foroud has received research support from NIH. The institution of Dr. Foroud has received research support from Michael J. Fox Foundation. The institution of Dr. Foroud has received research support from Parkinson Foundation. Dr. Foroud has received personal compensation in the range of $500-$4,999 for serving as a Member of an Advisory Committee with Mayo Clinic, University of Pennsylvania, Allen Institute, Mt. Sinai, Van Andel Institute.
Vladimir S. Kostic, MD, PhD Dr. Kostic has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. An immediate family member of Dr. Kostic has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Alkaloid. The institution of Dr. Kostic has received research support from Ministry of Â鶹´«Ã½Ó³»­, Science and Technological Development of Serbia.
Ritu Bagla, MD Dr. Bagla has nothing to disclose.
Reina Benabou, MD, PhD No disclosure on file
E. Ray Dorsey, MD, MBA Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seelos Therapeutics. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eden McCallum, LLP. Dr. Dorsey has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WebMD. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BioSensics. Dr. Dorsey has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Mediflix. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevance. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kairos Cinema, LLC. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America Inc.. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Dorsey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Advarra. Dr. Dorsey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medrhythms. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ANA. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for HMP Â鶹´«Ã½Ó³»­, LLP. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ADIVO Associates France. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for University of Toronto. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philadelphia Neurological Society. Dr. Dorsey has stock in Included Health. Dr. Dorsey has stock in Mediflix. Dr. Dorsey has stock in SemCap. Dr. Dorsey has stock in Synapticure. The institution of Dr. Dorsey has received research support from NIH/NINDS. The institution of Dr. Dorsey has received research support from Burroughs Wellcome . The institution of Dr. Dorsey has received research support from Michael J. Fox Foundation - Fox Insight. The institution of Dr. Dorsey has received research support from Michael J. Fox Foundation - Emerald. The institution of Dr. Dorsey has received research support from B. Thomas Golisano Foundation. The institution of Dr. Dorsey has received research support from Emerald Innovations, Inc.. The institution of Dr. Dorsey has received research support from Photopharmics Inc.. The institution of Dr. Dorsey has received research support from Averitas Pharma Inc.. The institution of Dr. Dorsey has received research support from DOD/Army Medical Research Acquisition Activity. The institution of Dr. Dorsey has received research support from NIH/NINDS.
Ricardo C. Reisin, MD Dr. Reisin has nothing to disclose.
Alejandro R. Marfil-Rivera, MD Dr. Marfil-Rivera has nothing to disclose.
Duygu Selcen, MD, FÂ鶹´«Ã½Ó³»­ Dr. Selcen has nothing to disclose.
Matthew J. Baker, MD No disclosure on file
Mefkure Eraksoy, MD Dr. Eraksoy has nothing to disclose.
Sean O'Riordan, MD Dr. O'Riordan has nothing to disclose.
Juan F. Gongora Rivera, MD, MD, MSc, PhD Dr. Gongora Rivera has nothing to disclose.
Anelyssa Cysne Frota D' Abreu, MD, PhD, MPH, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Cysne Frota D' Abreu has received research support from U.S. NIH Institute on Aging. The institution of Dr. Cysne Frota D' Abreu has received research support from Biogen. The institution of Dr. Cysne Frota D' Abreu has received research support from American College Of Radiology. The institution of Dr. Cysne Frota D' Abreu has received research support from COGNITION THERAPEUTICS, INC.. The institution of Dr. Cysne Frota D' Abreu has received research support from Eli Lilly. The institution of Dr. Cysne Frota D' Abreu has received research support from Jansen. Dr. Cysne Frota D' Abreu has received personal compensation in the range of $10,000-$49,999 for serving as a Lecturer with Pri_med.
Pablo Bonardo, MD Dr. Bonardo has nothing to disclose.
Lakshmi N. Ranganathan, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Ranganathan has nothing to disclose.
Andrew Lim, MD Dr. Lim has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Canada.
Teshamae Monteith, MD, FÂ鶹´«Ã½Ó³»­ Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Headache Society . Dr. Monteith has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Monteith has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merz. Dr. Monteith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva . Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³»­ . Dr. Monteith has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³»­. Dr. Monteith has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³»­ . Dr. Monteith has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Cephalalgia. Dr. Monteith has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for New England Journal of Medicine JW. The institution of Dr. Monteith has received research support from AbbVie. The institution of Dr. Monteith has received research support from lilly. The institution of Dr. Monteith has received research support from Ipsen. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Â鶹´«Ã½Ó³»­ with Medscape. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Â鶹´«Ã½Ó³»­ with Massachusetts Medical Society . Dr. Monteith has a non-compensated relationship as a President Elect with Florida Society of Neurology that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Monteith has a non-compensated relationship as a Editorial Board /Board Member with American Migraine Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Monteith has a non-compensated relationship as a Board Member with International Headache Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Monteith has a non-compensated relationship as a author with Pfizer that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Monteith has a non-compensated relationship as a author with Abbvie that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Monteith has a non-compensated relationship as a author with Theranica that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Meena R. Kannan, MD Dr. Kannan has nothing to disclose.
Tanya Lin, MD The institution of an immediate family member of Dr. Lin has received research support from National Science Foundation. The institution of Dr. Lin has received research support from Michael J Fox Foundation.
Suzanne Powell, MD Dr. Powell has nothing to disclose.
Madhu Soni, MD, FÂ鶹´«Ã½Ó³»­ Dr. Soni has received personal compensation in the range of $500-$4,999 for serving as a Physician Lead (Honorarium) in Women Leading in Neurology Program with Â鶹´«Ã½Ó³»­.
Richard L. Barbano, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Barbano has received personal compensation for serving as an employee of State of New York/Office of Mental Health. Dr. Barbano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie/Allergan. Dr. Barbano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 2nd MD. Dr. Barbano has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Barbano has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Visual Dx. Dr. Barbano has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for R L Barbano, MD,PhD, PLLC. The institution of Dr. Barbano has received research support from Fox Foundation. The institution of Dr. Barbano has received research support from Dystonia Study Coalition. The institution of Dr. Barbano has received research support from Revance. Dr. Barbano has received intellectual property interests from a discovery or technology relating to health care.
Janice F. Wiesman, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Diego Torres-Russotto, MD, FÂ鶹´«Ã½Ó³»­ Dr. Torres-Russotto has received personal compensation for serving as an employee of Movement Disorders Consulting, Inc. The institution of Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. The institution of Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. The institution of Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Revance. The institution of Dr. Torres-Russotto has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Anneal. Dr. Torres-Russotto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for IPSEN. Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. The institution of Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Torres-Russotto has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Your Nest Asset Solutions, LLC. Dr. Torres-Russotto has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Bright Future Asset Solutions, LLC.
Nicholas Szumski, MD No disclosure on file
Mary R. Rensel, MD, FÂ鶹´«Ã½Ó³»­ Dr. Rensel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for genentech. Dr. Rensel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG. Dr. Rensel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG. Dr. Rensel has stock in Brain Fresh LLC . The institution of Dr. Rensel has received research support from NMSS. The institution of Dr. Rensel has received research support from Roche- Genentech . The institution of Dr. Rensel has received research support from Biogen.
Stephen C. Cannon, MD No disclosure on file
Jennifer R. Molano, MD, FÂ鶹´«Ã½Ó³»­ Dr. Molano has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society . The institution of Dr. Molano has received research support from National Institutes of Health.
Esther Rawner, MD Dr. Rawner has received personal compensation for serving as an employee of Alkahest Inc. Dr. Rawner has received stock or an ownership interest from Alkahest Inc.
Mirla L. Avila, MD, FÂ鶹´«Ã½Ó³»­ Dr. Avila has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Genzyme, BMS, Serono. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen, genzyme, BMS. The institution of Dr. Avila has received research support from Texas Tech.
Kiran Thakur, MD, FÂ鶹´«Ã½Ó³»­ Dr. Thakur has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Delve Bio.
Maurizio Leone, MD Dr. Leone has nothing to disclose.
Danish Bhatti, MD, FÂ鶹´«Ã½Ó³»­ Dr. Bhatti has nothing to disclose.
Lana Chahine, MD, FÂ鶹´«Ã½Ó³»­ Dr. Chahine has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gray Matters Technology. The institution of Dr. Chahine has received research support from UPMC. The institution of Dr. Chahine has received research support from MJFF. The institution of Dr. Chahine has received research support from Denali/Biogen. Dr. Chahine has received publishing royalties from a publication relating to health care.
David J. Mikulis, MD Dr. Mikulis has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Neinstein Personal Injury Lawyers. Dr. Mikulis has received stock or an ownership interest from Thornhill Medical, Inc.. Dr. Mikulis has received intellectual property interests from a discovery or technology relating to health care.
Daniel Weintraub, MD Daniel Weintraub, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clintrex. Daniel Weintraub, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Daniel Weintraub, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Daniel Weintraub, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage. Daniel Weintraub, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scion. Daniel Weintraub, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Daniel Weintraub, MD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Modality.ai. Daniel Weintraub, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. Daniel Weintraub, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CuraSen. Daniel Weintraub, MD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Daniel Weintraub, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Daniel Weintraub, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Daniel Weintraub, MD has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorder Society. The institution of Daniel Weintraub, MD has received research support from NIH. The institution of Daniel Weintraub, MD has received research support from Fox Foundation. The institution of Daniel Weintraub, MD has received research support from IPMDS. Daniel Weintraub, MD has received intellectual property interests from a discovery or technology relating to health care.
Christopher Coffey, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Coffey has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Coffey has received research support from NIH. The institution of Dr. Coffey has received research support from Michael J Fox Foundation.
Miroslaw Brys, MD, PhD No disclosure on file
Belen Pascual, PhD The institution of Prof. Pascual has received research support from NIH. The institution of Prof. Pascual has received research support from NIH.
Camila Pupe, MD Dr. Pupe has nothing to disclose.
Connie C. Marras, MD Dr. Marras has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine Biosciences. The institution of Dr. Marras has received research support from Theravance Inc. The institution of Dr. Marras has received research support from Centogene.
Evanthia Bernitsas, MD, FÂ鶹´«Ã½Ó³»­ Dr. Bernitsas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Bernitsas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vanda. The institution of Dr. Bernitsas has received research support from Roche/Genentech.
Andrew R. Sas, MD, PhD Dr. Sas has nothing to disclose.
Imen Kacem, MD Dr. Kacem has nothing to disclose.
William D. Arnold, MD Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for La Hoffmann Roche. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadent Therapeutics . Dr. Arnold has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Arnold has received research support from NIH. The institution of Dr. Arnold has received research support from NMD Pharma. The institution of Dr. Arnold has received research support from Gilead Sciences. The institution of Dr. Arnold has received research support from CureSMA. Dr. Arnold has received intellectual property interests from a discovery or technology relating to health care.
Peggy Auinger Ms. Auinger has nothing to disclose.
Amy Z. Crepeau, MD Dr. Crepeau has nothing to disclose.
Liying Cui, PhD No disclosure on file
Jay Han, MD No disclosure on file
Teerin Liewluck, MD, FÂ鶹´«Ã½Ó³»­ Dr. Liewluck has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics. Dr. Liewluck has received publishing royalties from a publication relating to health care.
Corneliu C. Luca, MD Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Luca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Signant Health. Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott.
Michael J. Lyerly, MD, FÂ鶹´«Ã½Ó³»­ Dr. Lyerly has nothing to disclose.
Manoj Malhotra, MD Dr. Malhotra has received personal compensation for serving as an employee of Eisai.
Corey McMillan, PhD Dr. McMillan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. McMillan has received research support from Biogen. The institution of Dr. McMillan has received research support from NIH.
Sarah A. Morrow, MD, MSC, FRCPC, FÂ鶹´«Ã½Ó³»­ Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono/Merck. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SanofiGenzyme. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Morrow has received research support from Celgene. The institution of Dr. Morrow has received research support from SanofiGenzyme. The institution of Dr. Morrow has received research support from Novartis.
Kathleen Poston, MD, FÂ鶹´«Ã½Ó³»­ Dr. Poston has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Curasen Therapeutics, INC. Dr. Poston has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amprion, INC. Dr. Poston has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Poston has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Journal. Dr. Poston has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. Dr. Poston has stock in Curasen Therapeutics, INC. Dr. Poston has stock in Amprion, INC. The institution of Dr. Poston has received research support from NIH. The institution of Dr. Poston has received research support from Michael J Fox Foundation. The institution of Dr. Poston has received research support from Alzheimer's Drug Discovery Foundation . The institution of Dr. Poston has received research support from Lewy Body Dementia Association. Dr. Poston has received intellectual property interests from a discovery or technology relating to health care.
Christopher Streib, MD Dr. Streib has nothing to disclose.
Arun Venkatesan, MD, PhD Dr. Venkatesan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. The institution of Dr. Venkatesan has received research support from NIH. The institution of Dr. Venkatesan has received research support from U.S. DOD.
Carolina Barnett Tapia, MD Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD pharma. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx. The institution of Dr. Barnett Tapia has received research support from Department of defense. The institution of Dr. Barnett Tapia has received research support from Muscular dystrophy canada. The institution of Dr. Barnett Tapia has received research support from MgNet. The institution of Dr. Barnett Tapia has received research support from NIH. The institution of Dr. Barnett Tapia has received research support from Cartesian. The institution of Dr. Barnett Tapia has received research support from Alexion. Dr. Barnett Tapia has received intellectual property interests from a discovery or technology relating to health care.
Megan Hyland, MD The institution of Dr. Hyland has received research support from Biogen. The institution of Dr. Hyland has received research support from PCORI.
Tamar Bacon The institution of an immediate family member of Tamar Bacon has received research support from Novartis. The institution of an immediate family member of Tamar Bacon has received research support from Genentech. An immediate family member of Tamar Bacon has received publishing royalties from a publication relating to health care.
Orlando G. Barsottini, MD, PhD Dr. Barsottini has nothing to disclose.
Russell M. Bauer, PhD, ABPP No disclosure on file
Roberto Bomprezzi, MD, FÂ鶹´«Ã½Ó³»­ Dr. Bomprezzi has nothing to disclose.
Elisa Canu The institution of Elisa Canu has received research support from Italian Ministry of Health .
Neil Cashman, MD Dr. Cashman has received personal compensation for serving as an employee of ProMIS Neurosciences. Dr. Cashman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IONIS. Dr. Cashman has stock in ProMIS Neurosciences. The institution of Dr. Cashman has received research support from ProMIS Neurosciences. Dr. Cashman has received intellectual property interests from a discovery or technology relating to health care.
Melissa M. Cortez, DO The institution of Dr. Cortez has received research support from NIH NINDS. The institution of Dr. Cortez has received research support from Dysautonomia International. Dr. Cortez has received personal compensation in the range of $500-$4,999 for serving as a Content Expert, Reviewer, DSMB with NIH RECOVER project.
James T. Eckner, MD An immediate family member of Dr. Eckner has received personal compensation for serving as an employee of Autism Alliance of Michigan. The institution of Dr. Eckner has received research support from NIH. The institution of Dr. Eckner has received research support from Department of Defense. Dr. Eckner has received intellectual property interests from a discovery or technology relating to health care. Dr. Eckner has received personal compensation in the range of $500-$4,999 for serving as a CARE Consortium Publication Committee Member with Indiana University. Dr. Eckner has received personal compensation in the range of $0-$499 for serving as a Â鶹´«Ã½Ó³»­al Content Contributor with Move United.
Mark Frasier No disclosure on file
Dana Horakova Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Johanne M. Kaplan, PhD Dr. Kaplan has received personal compensation for serving as an employee of ProMIS Neurosciences. Dr. Kaplan has stock in ProMIS Neurosciences. Dr. Kaplan has received intellectual property interests from a discovery or technology relating to health care.
Chen Lin, MD The institution of Dr. Lin has received research support from VA.
Tamara Miller, MD Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics Therapeutics, Abbvie, Genentech. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono, TG Therapeutics, Biogen, Abbvie, Genentech, Lundbeck. The institution of Dr. Miller has received research support from Abbvie, Ipsen, Alexion, Pfizer, BMS, Genentech, ThermoFisher Scientific.
Cormac A. O'Donovan, MD Dr. O'Donovan has nothing to disclose.
Thomas L. Winder, PhD, FACMG Dr. Winder has nothing to disclose.
Lana Zhovtis Ryerson, MD, FÂ鶹´«Ã½Ó³»­ Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Yi-Cheng Zhu, MD, PhD Dr. Zhu has nothing to disclose.
Andrew M. Southerland, MD, FÂ鶹´«Ã½Ó³»­ Dr. Southerland has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Plaintiffs and Defense Cases related to Stroke and Vascular Neurology.. The institution of Dr. Southerland has received research support from American Heart Association. The institution of Dr. Southerland has received research support from NIH. The institution of Dr. Southerland has received research support from Abbvie Pharmaceuticals, Inc.. Dr. Southerland has received intellectual property interests from a discovery or technology relating to health care. Dr. Southerland has received intellectual property interests from a discovery or technology relating to health care.
Umer Akbar, MD Dr. Akbar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LANGaware.
Aron S. Buchman, MD No disclosure on file
Toby I. Gropen, MD Dr. Gropen has nothing to disclose.
Francois H. Jacques, MD No disclosure on file
Jonathan J. Halford, MD, FÂ鶹´«Ã½Ó³»­ Dr. Halford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life Sciences. Dr. Halford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Halford has received stock or an ownership interest from Corticare. The institution of Dr. Halford has received research support from Takeda. The institution of Dr. Halford has received research support from SK Life Sciences. The institution of Dr. Halford has received research support from Biogen.
Leigh E. Charvet, PhD Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Healthcare. Dr. Charvet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for YBrain. Dr. Charvet has stock in Johnson&Johnson.
James Conners, MD The institution of Dr. Conners has received research support from nih.
Christopher R. Newey, DO Dr. Newey has nothing to disclose.
Jennifer W. McVige, MD, FÂ鶹´«Ã½Ó³»­ Dr. McVige has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. McVige has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. Dr. McVige has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. McVige has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis. The institution of Dr. McVige has received research support from Amgen. The institution of Dr. McVige has received research support from Eli Lily. The institution of Dr. McVige has received research support from Biohaven/Pfizer. The institution of Dr. McVige has received research support from Lundbeck. The institution of Dr. McVige has received research support from Dent Family Foundation. The institution of Dr. McVige has received research support from Abbvie. The institution of Dr. McVige has received research support from Teva. The institution of Dr. McVige has received research support from Theranica. Dr. McVige has a non-compensated relationship as a Neurology Board with UCNS that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. McVige has a non-compensated relationship as a Board Exam Board Member with ABPN that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Christopher Hemond, MD The institution of Dr. Hemond has received research support from Consorium of Multiple Sclerosis Centers. The institution of Dr. Hemond has received research support from National Institute Of Neurological Disorders And Stroke of the National Institutes of Health. Dr. Hemond has received personal compensation in the range of $0-$499 for serving as a Member of Data Safety and Monitoring Board with National Institute Of Neurological Disorders And Stroke of the National Institutes of Health.
Laura C. Gioia, MD Dr. Gioia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier Inc.
Dimitrios Arkilo, MD Dr. Arkilo has received personal compensation for serving as an employee of Sage Therapeutics. Dr. Arkilo has received personal compensation for serving as an employee of Acadia Pharmaceuticals. Dr. Arkilo has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Arkilo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EcoR1. An immediate family member of Dr. Arkilo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. An immediate family member of Dr. Arkilo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medtronic. Dr. Arkilo has stock in Takeda Pharmaceuticals. Dr. Arkilo has stock in Acadia Pharmaceuticals. Dr. Arkilo has stock in Sage Therapeutics.
Kapil Arya, MBBS, DA, FAAP, FACNS, FÂ鶹´«Ã½Ó³»­ Dr. Arya has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Arya has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Arya has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scholar Rock.
Sumit Verma, MD Dr. Verma has nothing to disclose.
Lisa Laing No disclosure on file
Raghav Govindarajan, MD, FÂ鶹´«Ã½Ó³»­ Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT pharma. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT pharma . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Govindarajan has received research support from Band of Hope . The institution of Dr. Govindarajan has received research support from Alexion. Dr. Govindarajan has received publishing royalties from a publication relating to health care.
Murat Gokden Murat Gokden has nothing to disclose.
Andrei Ivashynka, MD, PhD Dr. Ivashynka has nothing to disclose.
Victoria Leavitt, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Leavitt has received research support from National Institutes of Health. The institution of Dr. Leavitt has received research support from National Multiple Sclerosis Society. The institution of Dr. Leavitt has received research support from Department of Defense. Dr. Leavitt has received intellectual property interests from a discovery or technology relating to health care.
Carrie Sammarco Carrie Sammarco has nothing to disclose.
Heidi B. Schwarz, MD, FÂ鶹´«Ã½Ó³»­ Dr. Schwarz has received personal compensation for serving as an employee of University of Rochester Medical Center. Dr. Schwarz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EBSCO. Dr. Schwarz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepost. Dr. Schwarz has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various Law Firms.
Yujie Wang, MD Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Wang has received research support from Genentech. The institution of Dr. Wang has received research support from uniQure. The institution of Dr. Wang has received research support from NIH/NINDS.
Carl A. Gold, MD, FÂ鶹´«Ã½Ó³»­ Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a CME Course Presenter with Oakstone.
Ruth Schneider, MD, FÂ鶹´«Ã½Ó³»­ Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Escape Bio. The institution of Dr. Schneider has received research support from The Michael J. Fox Foundation. The institution of Dr. Schneider has received research support from NIH. The institution of Dr. Schneider has received research support from Acadia Pharmaceuticals. The institution of Dr. Schneider has received research support from CHDI. The institution of Dr. Schneider has received research support from Biohaven Pharmaceuticals. The institution of Dr. Schneider has received research support from Parkinson Study Group. The institution of Dr. Schneider has received research support from The Michael J. Fox Foundation. The institution of Dr. Schneider has received research support from Bial. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Telemedicine Evaluator with Parkinson's Foundation.
Nawaz Hack, MD Dr. Hack has nothing to disclose.
Ryna Then, MD, FÂ鶹´«Ã½Ó³»­ Dr. Then has nothing to disclose.
Leah R. Hanson, PhD The institution of Dr. Hanson has received research support from NIA. The institution of Dr. Hanson has received research support from Merck Foundation. The institution of Dr. Hanson has received research support from Eagle Pharmaceuticals. The institution of Dr. Hanson has received research support from Research Grow Lab. The institution of Dr. Hanson has received research support from State of Minnesota. Dr. Hanson has received intellectual property interests from a discovery or technology relating to health care.
Tuhin Virmani, MD, PhD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Virmani has received research support from Parkinson's Foundation.
Anila Thomas, MD Dr. Thomas has nothing to disclose.
James R. Williams III, PhD Dr. Williams has received personal compensation for serving as an employee of Biogen. Dr. Williams has received stock or an ownership interest from Biogen.
Preet M. Varade, MD Dr. Varade has nothing to disclose.
Andrea Almeida, MD Dr. Almeida has nothing to disclose.
Hunaid Hasan, MD No disclosure on file
Vanessa Arnedo, MPH No disclosure on file
Livia A. Dutra, MD Dr. Dutra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. The institution of Dr. Dutra has received research support from Hospital Israelita Albert Einstein. The institution of Dr. Dutra has received research support from Laboratório Fleury. Dr. Dutra has received personal compensation in the range of $0-$499 for serving as a Speaker with Roche.
Leticia Tornes, MD, FÂ鶹´«Ã½Ó³»­ Dr. Tornes has nothing to disclose.
Saila Upadhyayula, MD Dr. Upadhyayula has nothing to disclose.
Moogeh Baharnoori Dr. Baharnoori has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Baharnoori has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme . Dr. Baharnoori has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Baharnoori has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD serono. Dr. Baharnoori has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Baharnoori has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Baharnoori has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Baharnoori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis . Dr. Baharnoori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb.
Natalie P. Witek, MD Dr. Witek has nothing to disclose.
Nathaniel M. Robbins, MD Dr. Robbins has received personal compensation in the range of $0-$499 for serving as a Consultant for Red Nucleus. Dr. Robbins has received personal compensation in the range of $0-$499 for serving as a Consultant for TDG Health. Dr. Robbins has received personal compensation in the range of $0-$499 for serving as a Consultant for Jupiter Life Science Consulting. Dr. Robbins has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Vaccine Injury Compensation Program. The institution of Dr. Robbins has received research support from Diamond Endowment Fund. The institution of Dr. Robbins has received research support from Reeves Endowment Fund. The institution of Dr. Robbins has received research support from Institute for Ethnomedicine. The institution of Dr. Robbins has received research support from Theravance. The institution of Dr. Robbins has received research support from Dysautonomia International. The institution of Dr. Robbins has received research support from National Institute of Health. The institution of Dr. Robbins has received research support from Vertex pharmaceutical. Dr. Robbins has received personal compensation in the range of $50,000-$99,999 for serving as a Locums neurohospitalist with Hayes Locums. Dr. Robbins has received personal compensation in the range of $500-$4,999 for serving as a Speaker with The Dysautonomia Project.
Meriem K. Bensalem Owen, MD Dr. Bensalem Owen has received personal compensation in the range of $0-$499 for serving as a Principle Investigator (PI) with Xenon. Dr. Bensalem Owen has received personal compensation in the range of $0-$499 for serving as a PI with UCB. Dr. Bensalem Owen has received personal compensation in the range of $0-$499 for serving as a PI with NeuroPace.
Bryan R. Due, PhD No disclosure on file
Carrie M. Hersh, DO, MSc, FÂ鶹´«Ã½Ó³»­ Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech_GN41791. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb . Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Hersh has received research support from Biogen. The institution of Dr. Hersh has received research support from Novartis. The institution of Dr. Hersh has received research support from Genentech_GN41791. The institution of Dr. Hersh has received research support from PCORI. The institution of Dr. Hersh has received research support from Bristol Myers Squibb.
Cullen M. O'Gorman, MBBS Dr. O'Gorman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen Australia Pty. An immediate family member of Dr. O'Gorman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck Australia. An immediate family member of Dr. O'Gorman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Otsuka.
Anindita Deb, MD, FÂ鶹´«Ã½Ó³»­ Dr. Deb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Altec.
Francois Bethoux, MD No disclosure on file
Nina J. Solenski, MD Dr. Solenski has received personal compensation in the range of $0-$499 for serving as an Expert Witness for Multiple. The institution of Dr. Solenski has received research support from HRSA . Dr. Solenski has received intellectual property interests from a discovery or technology relating to health care.
Nicholas Milano, MD Dr. Milano has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Jackson kelly.
Marcus Ng, MD The institution of Dr. Ng has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Paladin Canada. The institution of Dr. Ng has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Paladin Canada. Dr. Ng has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. The institution of Dr. Ng has received research support from Eisai. The institution of Dr. Ng has received research support from Paladin Canada. Dr. Ng has received publishing royalties from a publication relating to health care.
Jeffrey M. Chavin, MD, FÂ鶹´«Ã½Ó³»­ Dr. Chavin has received personal compensation for serving as an employee of Sanofi. Dr. Chavin has stock in Sanofi.
Rula Hajj-Ali, MD Rula Hajj-Ali, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Rula Hajj-Ali, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zena. Rula Hajj-Ali, MD has received publishing royalties from a publication relating to health care.
Thais Armangue, MD Dr. Armangue has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Armangue has received research support from ISCIII(Spanish institute of health) -PI21/00316, Marato TV3, La Caixa Research Foundadion, Pablove Foundation (689368), Torrons Vicens Foundation (PFNR0144), 2021 Invest AEP.
Ram N. Narayan, MD, FÂ鶹´«Ã½Ó³»­ Dr. Narayan has nothing to disclose.
Aravindhan Veerapandiyan, MD Dr. Veerapandiyan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen, Novartis,Edgewise Therapeutics, Pfizer, PTC Therapeutics, Sarepta Therapeutics, Inc., UCB Pharma, Catalyst, Entrada, Lupin, Percheron, ITF. Dr. Veerapandiyan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Veerapandiyan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Muscle and Nerve. The institution of Dr. Veerapandiyan has received research support from AMO Pharma, Capricor Therapeutics, Edgewise Therapeutics, FibroGen, Muscular Dystrophy Association, Novartis, Parent Project Muscular Dystrophy, Pfizer, RegenxBio, SolodBio and Sarepta Therapeutics. Dr. Veerapandiyan has received personal compensation in the range of $5,000-$9,999 for serving as a MD with PPMD, MDA.
Kara M. Smith, MD, FÂ鶹´«Ã½Ó³»­ Dr. Smith has received personal compensation in the range of $0-$499 for serving as a Consultant for PureTech. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Altec Inc. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal Pharmaceuticals. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Massachusetts Board of Medicine. The institution of Dr. Smith has received research support from NIH. Dr. Smith has received personal compensation in the range of $0-$499 for serving as a single time expert panel discussion contributor with Acadia.
Alison L. Walsh, MD Dr. Walsh has nothing to disclose.
Sevasti Bostantjopoulou-Kambouroglou, MD No disclosure on file
Jamie L. Adams, MD Dr. Adams has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Adams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Michael J. Fox Foundation. Dr. Adams has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BioSensics. The institution of Dr. Adams has received research support from NIH/NINDS. The institution of Dr. Adams has received research support from Biogen. The institution of Dr. Adams has received research support from The Michael J. Fox Foundation. The institution of Dr. Adams has received research support from Critical Path Institute. Dr. Adams has received personal compensation in the range of $500-$4,999 for serving as a KINECT-HD Steering Committee Member with Huntington Study Group. Dr. Adams has received personal compensation in the range of $500-$4,999 for serving as a ORCHESTRA-PD Steering Committee Member with Parkinson Study Group.
Ritesh Ramdhani, MD Dr. Ramdhani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Encora Therapeutics. Dr. Ramdhani has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Encora Therapeutics. The institution of Dr. Ramdhani has received research support from NIH. Dr. Ramdhani has received research support from Parkinson Alliance. Dr. Ramdhani has received intellectual property interests from a discovery or technology relating to health care.
Danielle Sandsmark, MD The institution of Dr. Sandsmark has received research support from NINDS. The institution of Dr. Sandsmark has received research support from BrainBox Solutions Inc. The institution of Dr. Sandsmark has received research support from Department of Defense.
Ernesto Aycardi, MD Dr. Aycardi has received personal compensation for serving as an employee of XENON. Dr. Aycardi has received stock or an ownership interest from XENON.
Jose L. Torres, MD Dr. Torres has nothing to disclose.
Sally V. Mathias, MD, FANA, FAES, FÂ鶹´«Ã½Ó³»­ Dr. Mathias has or had stock in Abbvie Inc.Dr. Mathias has received personal compensation in the range of $100,000-$499,999 for serving as a neurologist with Department of Veterans Affairs (VHA).
Riadh Gouider, MD, FÂ鶹´«Ã½Ó³»­ Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hikma. The institution of Dr. Gouider has received research support from Clinical Investigation Center. The institution of Dr. Gouider has received research support from Menactrims.
Lauren M. Massimo, PhD No disclosure on file
Pooja S. Raibagkar, MD, FÂ鶹´«Ã½Ó³»­ Dr. Raibagkar has nothing to disclose.
Idanis Berrios Morales, MD Dr. Berrios Morales has nothing to disclose.
Stephen M. Rao, PhD Stephen M. Rao, PhD has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Stephen M. Rao, PhD has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of the International Neuropsychological Society. Stephen M. Rao, PhD has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Psychologist. The institution of Stephen M. Rao, PhD has received research support from Biogen. Stephen M. Rao, PhD has received intellectual property interests from a discovery or technology relating to health care.
Xiangyi Meng, PhD Dr. Meng has nothing to disclose.
Raphael Schneider, MD Dr. Schneider has nothing to disclose.
Ekaterina Bakradze, MD Dr. Bakradze has nothing to disclose.
Caroline B. Braune, MD Dr. Braune has nothing to disclose.
Cyrus A. Raji, MD, PhD Prof. Raji has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainreader ApS. Prof. Raji has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apollo Health . Prof. Raji has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Neurevolution Medicine.
Guido J. Falcone, MD The institution of Dr. Falcone has received research support from NIH. The institution of Dr. Falcone has received research support from AHA.
James Clugston, MD, MS, CAQSM James Clugston, MD, MS, CAQSM has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for National Football League. James Clugston, MD, MS, CAQSM has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Pittsburgh Medical Center. James Clugston, MD, MS, CAQSM has received publishing royalties from a publication relating to health care.
Alanna Balbi, MD Dr. Balbi has nothing to disclose.
Paul Mehta Paul Mehta has nothing to disclose.
Tomas Uher Tomas Uher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Tomas Uher has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol myers. Tomas Uher has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Tomas Uher has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Tomas Uher has received research support from Novartis.
Oana M. Dumitrascu, MD, FÂ鶹´«Ã½Ó³»­ Dr. Dumitrascu has nothing to disclose.
Carlos Nos, MD Dr. Nos has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hoffmann-La Roche Ltd..
Leighton Mohl, MD Dr. Mohl has nothing to disclose.
Cristina Januario, MD No disclosure on file
Mahnaz Asgharnejad, PharmD Mahnaz Asgharnejad, PharmD has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Mahnaz Asgharnejad, PharmD has stock in GlaxoSmithKline. Mahnaz Asgharnejad, PharmD has stock in Takeda Pharmaceuticals.
Shlee S. Song, MD Dr. Song has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS. Dr. Song has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA/ASA. Dr. Song has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Hodes Milman. The institution of Dr. Song has received research support from DISCOVERY.
Ana Sofia Morgadinho, MD No disclosure on file
Ivan Da Silva, MD Dr. Da Silva has nothing to disclose.
Matthew Padrick, MD Dr. Padrick has nothing to disclose.
Murat Kurtuncu, MD Dr. Kurtuncu has nothing to disclose.
Oscar Martinez, MD No disclosure on file
Mubashir Pervez, MD, MBBS, FÂ鶹´«Ã½Ó³»­ Dr. Pervez has nothing to disclose.
Nicholas D. Osteraas, MD Dr. Osteraas has nothing to disclose.
Danielle S. Shpiner, MD An immediate family member of Dr. Shpiner has received personal compensation for serving as an employee of University of Miami. Dr. Shpiner has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Mission MSA. The institution of Dr. Shpiner has received research support from American Parkinson's Disease Association. The institution of Dr. Shpiner has received research support from CurePSP. The institution of Dr. Shpiner has received research support from Parkinson's Foundation. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Parkinson's Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Medtronic that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Boston Scientific that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbott that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbvie that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Ipsen that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Amneal that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Michael J. Fox Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Shpiner has a non-compensated relationship as a CoC Medical Director with CurePSP that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Mission MSA that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Merz that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Emmanuelle Lapointe, MD No disclosure on file
Marcela Uribe Roca The institution of Marcela Uribe Roca has received research support from Roche.
Mahmoud A. AbdelRazek, MD Dr. AbdelRazek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. AbdelRazek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. AbdelRazek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG therapeutics.
Firas Kaddouh, MD Dr. Kaddouh has nothing to disclose.
Mario Sousa, MD Dr. Sousa has nothing to disclose.
Lucas M. Araujo, Sr., MD No disclosure on file
David Sandness, MD Dr. Sandness has nothing to disclose.
Sara Razmjou-Schwarz, MD No disclosure on file
Tuncay Gunduz, MD The institution of Dr. Gunduz has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Pharmaceuticals. Dr. Gunduz has received research support from Turkish Neuroimmunology Society.
Jennifer A. Roggenbuck, MS, CGC The institution of Ms. Roggenbuck has received research support from Packard Foundation.
Maria S. Pacha No disclosure on file
Stuart J. McCarter, MD The institution of Dr. McCarter has received research support from NIH. The institution of Dr. McCarter has received research support from American Academy of Sleep Medicine Foundation.
Samantha J. LoRusso, MD Dr. LoRusso has nothing to disclose.
Jennifer Tay, MD No disclosure on file
K. H. Vincent Lau, MD Dr. Lau has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Dr. Lau has or had stock in Alnylam Pharmaceuticals.
Jason H. Margolesky, MD, FÂ鶹´«Ã½Ó³»­ Dr. Margolesky has nothing to disclose.
Marisa P. McGinley, DO, FÂ鶹´«Ã½Ó³»­ Dr. McGinley has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. McGinley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. McGinley has received research support from Biogen. The institution of Dr. McGinley has received research support from Genentech. The institution of Dr. McGinley has received research support from NIH. The institution of Dr. McGinley has received research support from AHRQ. The institution of Dr. McGinley has received research support from EMD Serono.
Shefali Dujari, MD Dr. Dujari has nothing to disclose.
Crystal J. Yeo, MD, PhD Dr. Yeo has nothing to disclose.
Kate M. Essad, MD, FÂ鶹´«Ã½Ó³»­ Dr. Essad has nothing to disclose.
Luciana V. Leon Cejas, MD Dr. Leon Cejas has nothing to disclose.
Thomas Finnegan, Jr., PhD Dr. Finnegan has nothing to disclose.
Jan Krasensky No disclosure on file
Steven P. Bondi, MD, MPA Dr. Bondi has nothing to disclose.
Smathorn Thakolwiboon, MD Dr. Thakolwiboon has nothing to disclose.
Anibal Chertcoff Anibal Chertcoff has nothing to disclose.
Leah Croll, MD Dr. Croll has nothing to disclose.
Ninad Desai, MBBS Dr. Desai has nothing to disclose.
Theodore Larson Theodore Larson has nothing to disclose.
Riccardo Manca, Msc No disclosure on file
Mariano Marrodan, MD Dr. Marrodan has nothing to disclose.
Amy Lin, MD Dr. Lin has nothing to disclose.
Christopher Tarolli, MD, FÂ鶹´«Ã½Ó³»­ Dr. Tarolli has received personal compensation for serving as an employee of University of Rochester. The institution of Dr. Tarolli has received research support from National Institutes of Health. The institution of Dr. Tarolli has received research support from Biogen. The institution of Dr. Tarolli has received research support from Neuron23. Dr. Tarolli has received personal compensation in the range of $500-$4,999 for serving as a Speaker, Committee Member with Â鶹´«Ã½Ó³»­. Dr. Tarolli has received personal compensation in the range of $500-$4,999 for serving as a Committee member with National Board of Medical Examiners. Dr. Tarolli has a non-compensated relationship as a Committee Member with Â鶹´«Ã½Ó³»­ that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Zoe Katsarou, MD No disclosure on file
Wendy Su, PhD No disclosure on file
Xiao-Tang Kong, MD, PhD Dr. Kong has nothing to disclose.
Maria Rosario G. Almeida, MD No disclosure on file
Jessica W. Templer, MD Dr. Templer has nothing to disclose.
Michael Popovich, MD Dr. Popovich has nothing to disclose.
Lixin Zhou Lixin Zhou has nothing to disclose.
Erin Smith, MD Dr. Smith has nothing to disclose.
Yuji Takahashi, MD, PhD The institution of Dr. Takahashi has received research support from Nihon Medi-Physics Co. Limit.. The institution of Dr. Takahashi has received research support from Takeda Pharmaceutical Company Limited.
Alejandro Kohler No disclosure on file
Andreia V. Faria, MD, PhD No disclosure on file
Luis F. Torres, MD Dr. Torres has nothing to disclose.
Michelle Devine, MD The institution of an immediate family member of Dr. Devine has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. The institution of an immediate family member of Dr. Devine has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astellas. An immediate family member of Dr. Devine has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. An immediate family member of Dr. Devine has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Â鶹´«Ã½Ó³»­. An immediate family member of Dr. Devine has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AGRIMS. An immediate family member of Dr. Devine has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Advances in Neurology. The institution of an immediate family member of Dr. Devine has received research support from Center of Individualized Medicine, Mayo Clinic.
Jessica Bloomfield, MD Dr. Bloomfield has nothing to disclose.
Stefan Nicolau, MD The institution of Dr. Nicolau has received research support from Muscular Dystrophy association. The institution of Dr. Nicolau has received research support from American Brain Foundation. The institution of Dr. Nicolau has received research support from American Neuromuscular Foundation.
Apameh Tarazi, MD No disclosure on file
Raffaella Umeton, MD, PhD, MMSc Dr. Umeton has nothing to disclose.
Daniela A. Pimentel Maldonado, MD, MSCR Dr. Pimentel Maldonado has nothing to disclose.
Jeffrey S. Phillips, PhD No disclosure on file
Foad Taghdiri, MD, MSc Dr. Taghdiri has nothing to disclose.
Leif Simmatis Mr. Simmatis has received personal compensation for serving as an employee of Cove Neurosciences. Mr. Simmatis has stock in Cove Neurosciences. Mr. Simmatis has received research support from University of Toronto .
Yuji Saitoh, MD, FÂ鶹´«Ã½Ó³»­ Dr. Saitoh has received stock or an ownership interest from Meiji Holdings Co. Ltd.. Dr. Saitoh has received stock or an ownership interest from Daiichi Sankyo Co. Ltd.. Dr. Saitoh has received stock or an ownership interest from Japan Tobacco Inc.. Dr. Saitoh has received stock or an ownership interest from Otsuka Holdings Co., Ltd.. Dr. Saitoh has received stock or an ownership interest from Fujifilm Holdings Corporation. Dr. Saitoh has received stock or an ownership interest from Johnson & Johnson. Dr. Saitoh has received stock or an ownership interest from 3M Company. The institution of Dr. Saitoh has received research support from Japan Agency for Medical Research and Development (AMED). Dr. Saitoh has received publishing royalties from a publication relating to health care. Dr. Saitoh has received publishing royalties from a publication relating to health care. Dr. Saitoh has received publishing royalties from a publication relating to health care.
David Liu No disclosure on file
Brit Mollenhauer No disclosure on file
Paolo Zanotti Fregonara Paolo Zanotti Fregonara has nothing to disclose.
Quentin Funk Quentin Funk has nothing to disclose.
Meixiang Yu No disclosure on file
Alexa Stone, MD No disclosure on file
Leticia Alejandra Olguín-Ramírez, Jr. No disclosure on file
Carl DeMoor Carl DeMoor has received personal compensation for serving as an employee of Biogen. Carl DeMoor has received stock or an ownership interest from Biogen. An immediate family member of Carl DeMoor has received personal compensation in the range of $100,000-$499,999 for serving as a Program Director with NIH.
Elizabeth Fisher Elizabeth Fisher has received personal compensation for serving as an employee of Biogen. Elizabeth Fisher has stock in Biogen. Elizabeth Fisher has received intellectual property interests from a discovery or technology relating to health care.
Prashant Natteru, MBBS Dr. Natteru has nothing to disclose.
Aleah Gillenkirk No disclosure on file
Lucrecia Bandeo Lucrecia Bandeo has nothing to disclose.
Fei Han Fei Han has nothing to disclose.
Zheng-Yu Jin No disclosure on file
Jun Ni Jun Ni has nothing to disclose.
George Nomikos No disclosure on file
Ming Yao Ming Yao has nothing to disclose.
Fei-Fei Zhai Fei-Fei Zhai has nothing to disclose.
Shu-Yang Zhang No disclosure on file
Stefan Blum, PhD, FRACP The institution of Dr. Blum has received research support from Merck. The institution of Dr. Blum has received research support from MSRA. The institution of Dr. Blum has received research support from PA Research Foundation.
Maryamnaz Zaribaf, MD No disclosure on file
Usaamah M. Khan, MD Dr. Khan has nothing to disclose.
Jaime Raymond Jaime Raymond has nothing to disclose.
Rahul D. Abhyankar, MD No disclosure on file
Angela Parsons, DO Dr. Parsons has nothing to disclose.
Hsien Lee Lau, MD No disclosure on file
Chrispine Oduor No disclosure on file
Tara Fox No disclosure on file
Karan Tarasaria, MBBS Dr. Tarasaria has nothing to disclose.
Somayeh Meysami, MD Dr. Meysami has nothing to disclose.
Sana Somani, MD, MBBS Dr. Somani has nothing to disclose.
Christopher Kenney No disclosure on file
Andres De Leon, MD Dr. De Leon has nothing to disclose.
Christopher B. Traner, MD Dr. Traner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuropace. Dr. Traner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell Inc. Dr. Traner has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for National Resident Matching Program .
Hartmut Uschmann, MD Dr. Uschmann has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Samson & Powers, PLLC.
Shaun Ajinkya, MD No disclosure on file
Kalpana Merchant No disclosure on file
David Weiner, MD No disclosure on file
Charles S. Venuto, MD No disclosure on file
Tracey H. Fan, DO Dr. Fan has nothing to disclose.
Joshua Tam, MD, PhD No disclosure on file
Karan K. Topiwala, MBBS No disclosure on file
Bhavika Kakadia, DO Dr. Kakadia has nothing to disclose.
Michael Byrne No disclosure on file
Pranusha Pinna, DO Dr. Pinna has nothing to disclose.
Jawahar Marimuthu, DM Dr. Marimuthu has nothing to disclose.
Jay Salpekar No disclosure on file
Reza Bavarsad Shahripour, MD Dr. Bavarsad Shahripour has nothing to disclose.
Zhen Xiao, PhD No disclosure on file
Lindsay M. Malatesta, MD No disclosure on file
Luis Fernandez No disclosure on file
GyeongMo Sohn, MD Dr. Sohn has nothing to disclose.
Talal Aboud, MD No disclosure on file
Lakshmi Pillai Ms. Pillai has nothing to disclose.
Saloua Mrabet, MD Dr. Mrabet has nothing to disclose.
Sishir Mannava, MD Dr. Mannava has nothing to disclose.
Keithan Sivakumar, MD Dr. Sivakumar has nothing to disclose.
Owen R. Pearson, MD Dr. Pearson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen . Dr. Pearson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Pearson has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Pearson has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Pearson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen .
Said Shukri, MD Dr. Shukri has nothing to disclose.
Daniel Garbin Di Luca, MD Dr. Garbin Di Luca has nothing to disclose.
Jacob Sambursky, MD Dr. Sambursky has nothing to disclose.
Michael Lillis, Jr., LMHC No disclosure on file
Jeffrey M. Kaplan, MD Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biohaven. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Kaplan has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Allergan. Dr. Kaplan has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lilly. Dr. Kaplan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Kaplan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Kaplan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Kaplan has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Kaplan has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Amgen. Dr. Kaplan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Viela. Dr. Kaplan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck.
Dmitry Khaitov, MD Dr. Khaitov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Reena P. Thomas, MD, PhD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Thomas has received research support from NIH. The institution of Dr. Thomas has received research support from California Institute of Regenerative Medicine. Dr. Thomas has received intellectual property interests from a discovery or technology relating to health care.
Kathryn Nichol, PhD Dr. Nichol has received personal compensation for serving as an employee of Greenwich Biosciences.
Virginia Baker, MD Dr. Baker has nothing to disclose.
Saurabh G. Shukla, MD Dr. Shukla has nothing to disclose.
Dixon Yang, MD Dr. Yang has nothing to disclose.
Ben Guikema, PhD No disclosure on file
Sanchari Datta, MBBS No disclosure on file
Kathryn T. Fong, MD Dr. Fong has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Fong has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Fong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Fong has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Fong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics.
George N. Ansoanuur, MD No disclosure on file
David Chaar, MD Dr. Chaar has nothing to disclose.
Parneet K. Grewal, MD The institution of Dr. Grewal has received research support from Bristol Myer Squibb Foundation. The institution of Dr. Grewal has received research support from IPSEN Global.
Hassan Aboul Nour, MD Dr. Aboul Nour has nothing to disclose.
Kyle Darpel, MD Dr. Darpel has nothing to disclose.
Ernesto Borrero-Quintana, MD, PhD No disclosure on file
Nicholas S. Streicher, MD Dr. Streicher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion . Dr. Streicher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovent. Dr. Streicher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Streicher has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. Dr. Streicher has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion.
Khaled Abdalla, MD Dr. Abdalla has nothing to disclose.
Golnaz Yadollahikhales, MD Dr. Yadollahikhales has nothing to disclose.
Ahmad Nehme, MD No disclosure on file
Ilana Green, MD Dr. Green has nothing to disclose.
Ghada A. Mahmoud Mohamed, MD Dr. Mahmoud Mohamed has nothing to disclose.
Shweta Varade, MD Dr. Varade has nothing to disclose.
Mihir Kakara, MD Dr. Kakara has nothing to disclose.
Abinayaa Purushothaman Ravichandran, MBBS Dr. Purushothaman Ravichandran has nothing to disclose.
Jennifer Chima, MD Dr. Chima has nothing to disclose.
Golnoush Akhlaghipour, MD Dr. Akhlaghipour has nothing to disclose.
Romana Hoeftberger Romana Hoeftberger has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology: Neuroimmunology and Neuroinflammation. Romana Hoeftberger has received personal compensation in the range of $500-$4,999 for serving as a speaker with BMS and UCB Biopharma.
Jaspreet Johal, MD Dr. Johal has nothing to disclose.
Pavan Patel, DO Dr. Patel has nothing to disclose.
Dilpreet Kaur-Spencer, MD No disclosure on file
Daniel A. Crespo Artunduaga, MD Dr. Crespo has nothing to disclose.
Christopher T. Brewer, MD, PhD An immediate family member of Dr. Brewer has received personal compensation for serving as an employee of Clinical Outcomes Solutions. An immediate family member of Dr. Brewer has received personal compensation for serving as an employee of Sprout Health Solutions.
Kodiak Carb No disclosure on file
Mariyam Humayun, MD Dr. Humayun has nothing to disclose.
James J. Rock III No disclosure on file
Carlos Alva-Diaz Carlos Alva-Diaz has nothing to disclose.
Raphael Breder No disclosure on file
Aliona Cucovici Dr. Cucovici has nothing to disclose.
Li-Ying Cui No disclosure on file
Michela Leocadi, MSc Dr. Leocadi has nothing to disclose.
Leigh Hartog No disclosure on file
Dhaval Trivedi No disclosure on file
Jeff Rodgers Jeff Rodgers has nothing to disclose.
Rod Middleton The institution of Mr. Middleton has received research support from MS Society.
Thiago D. Pinheiro, MD Dr. Pinheiro has nothing to disclose.
Jessica Bove No disclosure on file
Luisa A. Diaz-Arias, MD Dr. Diaz-Arias has nothing to disclose.
Megan T. Moyer, NP No disclosure on file
Aya A. Ouf, MBBS Dr. Ouf has nothing to disclose.
Kelly Rich, MS, CGC Ms. Rich has nothing to disclose.
Dung H. Nguyen, MD No disclosure on file
Vitalie S. Lisnic, MD No disclosure on file
Greer Waldrop, MD Dr. Waldrop has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Delve Bio. Dr. Waldrop has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech.
Nuriel Moghavem, MD Dr. Moghavem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Multiple Sclerosis Association of America. Dr. Moghavem has a non-compensated relationship as a Committee Member with National Multiple Sclerosis Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Moghavem has a non-compensated relationship as a Board Member with Los Angeles County Medical Association that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Elizabeth Matthews, MD Dr. Matthews has nothing to disclose.
Ildebrando H. Appollonio, MD Dr. Appollonio has nothing to disclose.
David Lawrence, DO No disclosure on file
Gregory N. Beatch, PhD Dr. Beatch has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc. Dr. Beatch has stock in Xenon Pharmaceuticals Inc. Dr. Beatch has received intellectual property interests from a discovery or technology relating to health care.
Felipe Rocha, MD No disclosure on file
Neisha Patel, MD Dr. Patel has nothing to disclose.
Preston Erickson, MD Dr. Erickson has nothing to disclose.
Jason T. Poon, MD Dr. Poon has nothing to disclose.
Maya Hrachova, DO Dr. Hrachova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SpringWorks Therapeutics.
Fabio F. Toso, MD Dr. Toso has nothing to disclose.
Kyle Ogami, MD No disclosure on file
Steven M. McKnight, MD Steven M. McKnight has nothing to disclose.
Ben Djebara Mouna No disclosure on file
Paul Comper, PhD, CPsych No disclosure on file
Avy Ronay, MD No disclosure on file
Michelle Bravo, MD Dr. Bravo has nothing to disclose.
Vivian Yang, MD Dr. Yang has nothing to disclose.
Lahoud Touma, MD Dr. Touma has nothing to disclose.
Karen Misquitta No disclosure on file
Paige Sutton, MD Dr. Sutton has nothing to disclose.
Francis Brunet, MD No disclosure on file
Andrew Swayne, MBBS No disclosure on file
Christian Gericke, MD PhD MPH, FÂ鶹´«Ã½Ó³»­ Dr. Gericke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medicines Australia. Dr. Gericke has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Australian Hospital and Healthcare Association. Dr. Gericke has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various Australian Government Agencies.
Ashley Weng, MD Dr. Weng has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx.
Irene Koulinska Irene Koulinska has received personal compensation for serving as an employee of Biogen.
Lucia Ryll No disclosure on file
Erick M. Roff, DO No disclosure on file
Benjamin T. Alwood, MD Dr. Alwood has nothing to disclose.
Mei-jun Shu Mei-jun Shu has nothing to disclose.
Micaela Hernandez, MD Dr. Hernandez has nothing to disclose.
Michael Brumm No disclosure on file
Joanne M. Wagner, PhD, PT Dr. Wagner has received personal compensation for serving as an employee of Xenon Pharmaceuticals, Inc.. Dr. Wagner has stock in Biogen. Dr. Wagner has stock in Xenon Pharmaceuticals, Inc..
Julianne Hall, MD Dr. Hall has nothing to disclose.
Paige Buddenhagen No disclosure on file
Frederick Bassal, DO Dr. Bassal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MARAbio.
Richa Thakkar, DO Dr. Thakkar has nothing to disclose.
Rosa Sommer No disclosure on file
Jessica Powell No disclosure on file
Rene D. Gleizer, Jr., MD Dr. Gleizer has nothing to disclose.
Hugo Marion-Moffet, MD No disclosure on file
Bastien Rioux, MD Dr. Rioux has nothing to disclose.
Zachary Goodwin, MD Dr. Goodwin has nothing to disclose.
Maliha Hakim, MD No disclosure on file
Veronika Solnicky, MD No disclosure on file
Beibei Zhao Beibei Zhao has received intellectual property interests from a discovery or technology relating to health care.
Bruna de Freitas Dias, MD Dr. Dias has nothing to disclose.
Chelsea M. Herbert Ms. Herbert has nothing to disclose.
Charlotte Wahle Charlotte Wahle has nothing to disclose.
Gillian Ingram No disclosure on file
Ingrid Ichesco No disclosure on file
Tatiana L. Christmas, MD No disclosure on file
Nupur Brahmbhatt, MD No disclosure on file
Arpan Patel, MBBS Dr. Patel has nothing to disclose.
Amina A. Mohamed, MD No disclosure on file
Vivian R. Jaber, MD, PhD No disclosure on file
Wael Asaad No disclosure on file
Walter J. Atwood, PhD No disclosure on file
Zihuai He Zihuai He has nothing to disclose.
Aliyah J. Glover Miss Glover has nothing to disclose.
Aleta Svitak, MS Aleta Svitak has nothing to disclose.
Denisse G. Martinez Roque, Jr. Miss Martinez Roque has nothing to disclose.
Rachel Galioto Rachel Galioto has nothing to disclose.
Anna Vasilevskaya, PhD Anna Vasilevskaya has nothing to disclose.
Maya N. Hatch, PhD Maya Hatch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bioniks. Maya Hatch has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum. The institution of Maya Hatch has received research support from Fulcrum Therapeutics.
Horacio Chapa-Martinez No disclosure on file
Pakinam Aboulsaoud Pakinam Aboulsaoud has nothing to disclose.
Justin Hoffman, DO No disclosure on file
Mar Tintoré, MD, PhD The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche . The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme . The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela bio. The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Mar Tintoré, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Mar Tintoré, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Mar Tintoré, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Mar Tintoré, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. The institution of Mar Tintoré, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parexel and UCB Biopharma. Mar Tintoré, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Multiple Sclerosis Journal: Experimental, Translational and Clinical. The institution of Mar Tintoré, MD, PhD has received research support from Fundació La Marató de TV3. The institution of Mar Tintoré, MD, PhD has received research support from Instituto de Salud Carlos III. The institution of Mar Tintoré, MD, PhD has received research support from Instituto de Salud Carlos III. The institution of Mar Tintoré, MD, PhD has received research support from Instituto de Salud Carlos III.
Enxu Zhao No disclosure on file
Shameer Rafee, MBBS, PhD Dr. Rafee has nothing to disclose.
Tehila Eilam-Stock, PhD Dr. Eilam-Stock has nothing to disclose.
Kevin Pacheco-Barrios, MD Dr. Pacheco-Barrios has nothing to disclose.
Ryan T. Muir, MD Dr. Muir has nothing to disclose.
Ramya Tadipatri, MD Dr. Tadipatri has nothing to disclose.
Fawaz Philip Tarzi, MD Dr. Tarzi has nothing to disclose.
Ramiro G. Castro Apolo, MD Dr. Castro Apolo has nothing to disclose.
Ann Oh Dr. Oh has nothing to disclose.
John Sanderson, MD Dr. Sanderson has nothing to disclose.
Barrie L. Zerwic, MD Dr. Schmitt has nothing to disclose.
David J. Adams, MD Dr. Adams has nothing to disclose.
Cynthia Xu, MD No disclosure on file
Jaehyun Kim, MD No disclosure on file
Ryan Hewitt, MD No disclosure on file
Brianna Albert, DO No disclosure on file
Leah Millsap, PhD Dr. Millsap has nothing to disclose.
IOANNIS DAGKLIS No disclosure on file
Celia V. Zinger, MD Celia Zinger has received personal compensation for serving as an employee of Ovid Therapeutics.
Nikolas Kinney No disclosure on file
Molly Bates, MD Dr. Bates has nothing to disclose.
Sara Hooshmand, MD Dr. Hooshmand has nothing to disclose.
Gabriela A. Lopes, MD No disclosure on file
Rebecca A. Burgos No disclosure on file
John C. Feemster, MD Mr. Feemster has nothing to disclose.
Patrick Eugeni Mr. Eugeni has nothing to disclose.
Hafsa Bareen Syeda, MBBS Dr. Syeda has nothing to disclose.